People

Siddharth Tawker self-publishes a Consuma professional affiliation and describes work on consumer research following marketing experience. Consuma names him in its current MarTech/DigiPlus event recap. No exact job title or employment dates are disclosed in the accessible source.

Akash Bhargava works on product and growth at Consuma after earlier work at Kirana Club. His own posts describe joining Consuma and building its product and research publication; the current SpacetimeDB event organizer names him VP Product & Growth at Consuma.

Siddhartha Sharma leads sales at Consuma. His own announcement describes joining Consuma after Darwinbox and earlier enterprise-SaaS founding and go-to-market work; Consuma’s current event publication expressly calls him its Head of Sales.

Consuma publishes Riya as Research Analyst. The company card does not disclose a surname or individual profile link.

Consuma publishes Ankur D under Engineering. The company card gives a surname initial without an individual profile link; the initial is preserved rather than expanded.

Consuma publishes Sachin Krishna under Product Marketing. This company-directory attribution does not establish the dates or exclusivity of his employment.

Consuma publishes Rithika under Growth Marketing. The company card does not disclose a surname or individual profile link.

Consuma publishes Vibhav under Growth & Strategy. The company card does not disclose a surname or individual profile link.

Yash Nikhil Mutnalkar is published in Consuma's Founder’s Office as Yash Mutnalkar. His same personal profile publishes the fuller name and Consuma product and fundraising updates.

Sachin Shankar Balasubramanyam works on Consuma engineering. His July2023 self-published announcement described moving from a16-month internship to full-time work at Consuma AI; an attached PESU Venture Labs profile identified him as lead developer working on its web-data, AI and NLP architecture. The current company directory publishes him as Sachin Shankar under Engineering.

Abhilash Madabhushi founded Consuma in2021 and leads its product, innovation and technology work. Consuma develops AI software for consumer and market research.

Shane Ang (Shane Ang) is published in Korea Investment Partners’ current Singapore Partners directory as Director. Shane began his career launching a design business while studying Digital Animation at Nanyang Technological University, gaining firsthand experience in entrepreneurship. He later joined the VC team at a Singapore-based multi-family office, where he was drawn to the dynamic intersection of talent, technology, and capital markets — leading him to pursue venture capital full-time at Korea Investment Partners. He focuses on early and growth stage investments across Asia in the Proptech and Consumer sectors, and has recently been spending more time in Fintech and Insurtech — spaces where distribution dynamics and regulation tend to create durable moats. He looks for companies that can leverage these structural advantages into lasting competitive positions. Published education: B.F.A., Nanyang Technological University. The primary profile’s career/background list names Golden Equator Ventures; undated entries are not independently verified concurrent appointments. Published areas: Fintech, Insurtech, Consumer. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Synclare Kim (김종현) is published in Korea Investment Partners’ current Singapore Partners directory as Head of KIP Singapore. Synclare leads KIP Singapore, with a focus on fintech investments. He previously worked in financial industry research at Samsung Economic Research Institute and Woori Finance Research Institute, and built his investment experience at Mirae Asset Venture Investment and KTB Network. He is particularly interested in technologies that improve access to financial services and address inefficiencies in existing financial systems. He looks for founders who can turn those technologies into products and businesses that work in the real market. Published education: Ph.D., Management Information Systems, Graduate School of Business, Sungkyunkwan University. The primary profile’s career/background list names KTB Network, Mirae Asset Venture Investment, Samsung Economic Research Institute, Woori Finance Research Institute; undated entries are not independently verified concurrent appointments. Published areas: IT Convergence, Fintech, Insurtech. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Jieun Kim (김지은) is published in Korea Investment Partners’ current U.S. Partners directory as Assistant Manager. Jieun(Jinny) is an Assistant Manager at KIP US, where she is responsible for accounting, monthly and annual financial closing, and external audit coordination. She also supports the day-to-day operations of the U.S. office and manages reporting and other requests from KIP headquarters. Through accurate financial management and reliable operational support, she helps maintain an effective operating environment for KIP US and enables the investment team to remain focused on its core investment activities. Published education: B.B.A., Business Administration, Duksung Women's University. The primary profile’s career/background list names Harley-Davidson of Korea; undated entries are not independently verified concurrent appointments. Published areas: Corporate Management, Accounting, Finance Management. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Minjoon Park (박민준) is published in Korea Investment Partners’ current U.S. Partners directory as Associate. Minjoon invests across AI, robotics, space, and energy, from early to growth stages. He focuses on companies with the potential to create new markets and build long-term value. He works closely with founders and supports portfolio companies across fundraising and growth. Rather than following short-term trends, Minjoon looks for businesses with lasting potential. Published education: B.A., Economics, Oberlin College. The primary profile’s career/background list names Korea Investment Partners; undated entries are not independently verified concurrent appointments. Published areas: AI, Robotics, Energy. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Keila Kim (김연주) is published in Korea Investment Partners’ current U.S. Partners directory as S. Associate. Keila focuses on life sciences investments across biopharma, next-generation biotechnology platforms, and the convergence of biology and technology. She joined Korea Investment Partners in 2022 as a biotech analyst and has since worked on both direct and GP investments in Silicon Valley. Her familiarity with both the U.S. and Korean biotech ecosystems also supports her work across cross-border investment opportunities. She evaluates companies based on scientific differentiation, commercialization potential, and scalability. She is particularly interested in companies where strong science can translate into viable products, therapies, and healthcare solutions with the potential to reach meaningful scale. Published education: B.S., Biology, University of California, Berkeley. The primary profile’s career/background list names Korea Investment Partners; undated entries are not independently verified concurrent appointments. Published areas: Bio, Healthcare, Pharma. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Jin Yoon (윤서진) is published in Korea Investment Partners’ current U.S. Partners directory as Principal. Jin began his venture investing career at Plug and Play, where he worked closely with early-stage founders and supported investment activities. The experience shaped his interest in companies that address problems at a systems level and change how organizations and industries operate. He invests across AI, robotics, space and defense, and deep tech in the U.S. and Europe. He focuses on strong founding teams tackling important problems with technologies that have the potential to reshape industries. Published education: B.S., Management Information Systems & Supply Chain Management, Kelley School of Business, Indiana University M.S., Technology Entrepreneurship, University of Notre Dame. The primary profile’s career/background list names Plug and Play Investment Team; undated entries are not independently verified concurrent appointments. Published areas: DeepTech, Software, Mobile. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Mijin Han (한미진) is published in Korea Investment Partners’ current U.S. Partners directory as Principal. Mijin began her career at PwC in transaction advisory and audit before moving into investing at NT Capital. She later joined McKinsey & Company, where she advised private equity clients on technology-related projects. Her experience across advisory and investing eventually led her to focus on venture capital. She invests primarily in healthcare and fintech. She is interested in companies tackling problems that remain poorly solved and looks closely at whether the market is large enough, the business can scale, and the team can execute. Published education: B.A., English Literature, Rice University M.B.A.,Booth School of Business, University of Chicago. The primary profile’s career/background list names McKinsey, NT Capital, PwC; undated entries are not independently verified concurrent appointments. Published areas: Healthcare, Fintech, Insurtech. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Joon Hyun (현석준) is published in Korea Investment Partners’ current U.S. Partners directory as Director. Joon began his career at Korea Investment Partners and has since invested in more than 40 companies across North America, Europe, and Asia. He believes in building relationships and making investments on principles he can stand behind, even when the outcome does not go as planned. Rather than looking at companies in isolation, he considers the broader direction of technology and industry and looks for teams that can help shape what comes next. He invests across AI, robotics, bio, and platforms, with a focus on technologies that can change how industries are built and operate. Published education: B.A., Economics, University of California, Berkeley. The primary profile’s career/background list names Korea Investment Partners; undated entries are not independently verified concurrent appointments. Published areas: ICT, Bio, Healthcare. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

David Suh (서정훈) is published in Korea Investment Partners’ current U.S. Partners directory as Head of KIP US. David began his career as a trader at Morgan Stanley and RBS in New York and Hong Kong. He later founded an e-commerce startup in Singapore and led strategic planning for Samsung’s mobile business in Southeast Asia, building experience across both finance and operating businesses. He then spent more than a decade at Samsung Ventures America, leading investments across semiconductors and deep tech and helping build the organization into one of Silicon Valley’s most active deep-tech investment platforms. In 2026, David joined Korea Investment Partners as Head of KIP US, where he leads the firm’s U.S. expansion and strengthens its global investment capabilities. He focuses on areas with strong structural growth, including AI data centers and infrastructure, energy, vertical AI, and bio and healthcare. Published education: B.S., Economics, Wharton School, University of Pennsylvania. The primary profile’s career/background list names Morgan Stanley, RBS, Samsung Ventures America; undated entries are not independently verified concurrent appointments. Published areas: Semiconductor, AI, Deeptech. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Cutey Lv (Cutey Lv) is published in Korea Investment Partners’ current China Partners directory as Assistant Manager. Cutey is an Assistant Manager on the KIP Shanghai, handling HR and financial management. She joined KIP right after graduating in 2015, having earned her bachelor's degree in Tourism Management from Kangwon National University, and previously worked at Postal Savings Bank of China Co., Ltd. She currently manages core financial functions including fund settlements, expense reimbursement review, bill and seal management, bank account reconciliation, payroll and benefits disbursement, procurement for the Beijing and Shanghai offices, and fund risk management. She is now looking to expand beyond execution into fund management, guided by core principles of cash flow visibility, pre-investment expenditure compliance, and audit readiness. Published education: B.B.A., Tourism Management, Kangwon National University. The primary profile’s career/background list names Postal Savings Bank of China; undated entries are not independently verified concurrent appointments. Published areas: HR, Finance Management, Accounting. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

David Hong (David Hong) is published in Korea Investment Partners’ current China Partners directory as Manager. David majored in Law at Beijing University of Chinese Medicine and built a solid foundation in corporate compliance, legal documentation, and administrative operations at Samsung Electronics China. He holds multiple professional qualifications, including the PRC Bar, CTA, CMA, CIA, and PMP certifications. He currently leads day-to-day financial operations for FMC and its funds at Korea Investment Partners' Shanghai office, overseeing accounting, cash flow management, financial reporting, and regulatory compliance. He also carries out post-investment activities such as portfolio monitoring, performance tracking, and operational support for portfolio companies, integrating his legal, tax, financial, and project management expertise into fund operations to support sustainable value creation. Published education: B.L., Law, Beijing University of Chinese Medicine. The primary profile’s career/background list names Samsung Electronic (China), Perfect CPA; undated entries are not independently verified concurrent appointments. Published areas: Accounting, Finance Management, Fund Management. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Cathy Jin (Cathy Jin) is published in Korea Investment Partners’ current China Partners directory as Director. Cathy is Director of KIP China, having joined right after university in 2009 and built her entire career there. Her role spans fundraising support, portfolio investment & exit support, fund distributions and liquidation, investor relations, AMAC compliance, finance/tax, and AML — including managing multiple QFLP and JV funds through their full lifecycle from formation to liquidation. With over 17 years of experience in cross-border VC fund operations, she brings deep expertise in complex fund structuring and multi-jurisdiction execution, while also exploring AI to improve workflow efficiency. Cathy is a CPA, holds a B.A. from Central University of Finance and Economics, and is fluent in Chinese, Korean, and English. Published education: B.A., Public Administration, Central University of Finance and Economics. The primary profile’s career/background list names KIP China; undated entries are not independently verified concurrent appointments. Published areas: Fund Planning, Fund Management, Fundraising. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Bruce Hong (홍경진) is published in Korea Investment Partners’ current China Partners directory as Associate Director. Bruce, Associate Director, is based at KIP's Beijing office, managing the firm's China-focused funds and leading new fund formation. He previously spent five years at KVIC's China office running the Korea Fund of Funds' China allocation program, and building investment and industry networks in China. He brings deep insight into China's capital markets and industrial ecosystem to KIP. He views venture investment as backing future value and innovation for social progress and investor returns, and sees the firm as a platform for shared success. Published education: B.A., Political Science and Law, Fudan University. The primary profile’s career/background list names Lotte Confectionery China Holdings, KVIC China office; undated entries are not independently verified concurrent appointments. Published areas: Fund Planning, Fund Management, LP Relations. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Reco Yu (Reco Yu) is published in Korea Investment Partners’ current China Partners directory as Director. Reco is Director of the Risk Management at KIP Shanghai. She is instrumental in shaping the firm's investment success by leading comprehensive financial due diligence and managing the ongoing accounting activities of portfolio companies. Prior to joining KIP China, she worked at Intertek and KPMG. She received her BBM from Shanghai University of Finance and Economics. Published education: B.B.M., Business Management, Shanghai University of Finance and Economics. The primary profile’s career/background list names Intertek, KPMG; undated entries are not independently verified concurrent appointments. Published areas: Risk Management, Audit, FDD. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Charlie Wang (Charlie Wang) is published in Korea Investment Partners’ current China Partners directory as Director. Charlie is the Director of the Compliance Team at KIP, where he oversees legal affairs related to KIP China's operations, ensuring regulatory compliance and risk mitigation for the firm's activities in the region. Prior to joining KIP, Charlie was a partner at Grandall law firm. Before that, he practiced as an associate in several prominent law firms, including King & Wood, Huatang, and Gray & Perkins (Beijing Office). He holds both an LL.B. and LL.M. from Renmin University of China. With deep expertise in legal due diligence and compliance frameworks, Charlie plays a critical role in safeguarding KIP's investments and supporting the firm's strategic objectives in the dynamic market of the Greater China region. Published education: LL.M. / LL.B., Renmin University of China. The primary profile’s career/background list names Grandall law firm, King & Wood Mallesons, Huatang law firm, Gray & Perkins Beijing Office; undated entries are not independently verified concurrent appointments. Published areas: Legal, CDD, Risk Management. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Ziye Song (Ziye Song) is published in Korea Investment Partners’ current China Partners directory as VP. Ziye is a VP of Investment at Korea Investment Partners' Shanghai office. Prior to joining KIP, he worked at Salesforce in San Francisco, Tencent in Shenzhen, and Ceyuan Ventures in Beijing, gaining a combination of product experience in Silicon Valley, Chinese tech platform experience, and early-stage venture investing experience. He holds a bachelor's degree in Electrical Engineering and Computer Sciences (EECS) from UC Berkeley. He focuses on early- to growth-stage technology investments, primarily from Series A to Series C, where technical differentiation has begun to translate into product validation, customer adoption, or strategic supply-chain relevance. His technical training shapes his investment approach: he is particularly interested in companies where deep engineering capability, product-market timing, and operating excellence jointly determine long-term value creation, combined with clear commercialization paths and strong company-building execution across technology, go-to-market, and team development. Published education: B.S., Electrical Engineering and Computer Science, University of California, Berkeley. The primary profile’s career/background list names Salesforce, Tencent; undated entries are not independently verified concurrent appointments. Published areas: AI, Robotics, Consumer. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Leo Lin (Leo Lin) is published in Korea Investment Partners’ current China Partners directory as Director. Prior to joining Korea Investment Partners, Leo worked at SIG Asia Investment and Baidu, gaining experience across both technology and investing. With a background in physics, he focuses on understanding how emerging technologies scale into real-world industries and translating those insights into investment opportunities. He invests in AI, robotics, and consumer sectors, with a focus on real-world applicability and scalability of technology. In complex and fast-moving environments, he focuses on identifying core signals amid noise and backing companies with the potential for sustained, long-term growth. Published education: B.S., Physics, Peking University. The primary profile’s career/background list names CDH Funds, SIG Asia Investment, Baidu Strategy Office; undated entries are not independently verified concurrent appointments. Published areas: AI, Robotics, Semiconductor. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Richard Cui (Richard Cui) is published in Korea Investment Partners’ current China Partners directory as Director. Prior to joining Korea Investment Partners, Richard worked at Mitsui Global Investment and Samsung (China) R&D, building experience across both capital markets and technology development. He entered the VC industry over 15 years ago, drawn to what he describes as the ongoing interplay between technology and humanity — a space where exceptional talent comes together to shape the future. He focuses on opportunities across AI/Computing, Robotics, Space, Energy, and cross-border investments. He takes a conviction-driven approach, investing without being constrained by stage or valuation when confident in a company’s ability to reach its next milestone. This approach has led to multiple successful exits through M&A and IPO. Published education: B.S. in Business & Computer Science, Tianjin University. The primary profile’s career/background list names Mitsui Global Investment, Samsung (China) R&D; undated entries are not independently verified concurrent appointments. Published areas: TMT, AI, DeepTech. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Michelle Zheng (Michelle Zheng) is published in Korea Investment Partners’ current China Partners directory as Associate Partner. Michelle is Associate Partner at KIP's Shanghai office. Prior to joining KIP, she worked at Fosun Pharma, Newmargin Capital, and Ipsos Group S.A., building experience across corporate strategy consulting, venture capital, and the biotech sector. She graduated from NUS (National University of Singapore) with an MBA and from Shanghai University with a Bachelor's degree in Business Management. She focuses on early-to-growth-stage tech and hard-tech investments (Series A–C). She believes technology must translate into validated applications and tangible customer value, favoring companies with strong R&D, clear commercial paths, and robust execution. Published education: B.B.M., Business Management, Shanghai University M.B.A., Concordia University. The primary profile’s career/background list names Fosun Pharma, New Margin, IPSOS; undated entries are not independently verified concurrent appointments. Published areas: Bio, Healthcare, Pharma. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Grace Kim (김지수) is published in Korea Investment Partners’ current China Partners directory as Head of KIP Beijing. Grace, Head of KIP's Beijing Office, previously served as a full-time professor at Paichai University before joining the Korea Health Industry Development Institute (KHIDI). In 2012, she was posted as KHIDI's China branch chief, leading the Korean health industry's expansion into China. Through that experience, she recognized that corporate exchange alone couldn't drive real outcomes without capital, which deepened her appreciation for the role of VC — leading her to join KIP's China division in 2015. She focuses on early-stage investments across healthcare, bio, AI, and consumer sectors. In pharmaceuticals she favors a fast-follower strategy, while in other areas she prioritizes CEO drive, whether the technology solves a genuine market pain point, and the potential to secure data for AI and future industries. Published education: Ph.D., Acupuncture-Moxibustion Tuina, Beijing University of Traditional Chinese Medicine. The primary profile’s career/background list names Korean Embassy(China), KHIDI, Baejae University; undated entries are not independently verified concurrent appointments. Published areas: Bio, Healthcare, Pharma. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Hudson Ho (호경식) is published in Korea Investment Partners’ current China Partners directory as Head of KIP China (Shanghai). Hudson, Managing Partner, felt the limits of advising clients from the outside as a consultant and concluded it would be more meaningful to execute directly or share in the results himself. In 1999, he founded and ran an internet company, growing it to about 20 employees and raising venture capital, before selling it to a listed company in its second year — an experience that drew him into VC and led him to join KIP. In Korea, he invested in semiconductor and internet platform companies such as Neofidelity, WiSol, ICreditable, and AfreecaTV. After establishing KIP's China office, he expanded into consumer internet, high-tech, and biotech investments including DiDi, Henlius, Weimob, and Ambiq. He places the highest value on a founder's problem-solving ability, leading early-stage investments in industries with strong expected growth and selecting companies that can secure clear technological differentiation. Published education: B.B.A., Business Administration, Seoul National University. The primary profile’s career/background list names Accenture (Anderson Consulting); undated entries are not independently verified concurrent appointments. Published areas: TMT, Bio, Semiconductor. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Seungmin Lee (이승민) is published in Korea Investment Partners’ current Operations Partners directory as Associate. Seungmin Lee is an Associate on the Fund Planning & Management Team, where he supports funds throughout their lifecycle, from formation through liquidation. His responsibilities span fund formation and administration as well as coordination with LPs, startups, and other stakeholders involved in the investment process. Before joining Korea Investment Partners, he evaluated early-stage investment opportunities at Schmidt and later gained hands-on fund management experience at Mirae Asset Capital. His experience across both investment evaluation and fund administration has given him a broad perspective on managing investments beyond the initial decision. Published education: B.A., Economics, Hanyang University. The primary profile’s career/background list names Korea Investment Partners; undated entries are not independently verified concurrent appointments. Published areas: Fund Planning, Fund Management, Investment Operations. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Jeonghyun Cha (차정현) is published in Korea Investment Partners’ current Operations Partners directory as Assistant Manager. Jeonghyun is an Assistant Manager on the Asset Management Team, where he is responsible for fund accounting, financial reporting, external audit coordination, and tax matters. His role focuses on maintaining the accuracy and timeliness of financial information across fund operations. Before joining Korea Investment Partners, he worked on the accounting team at KOSDAQ-listed cybersecurity company Igloo Corporation. His responsibilities included financial closing, external audits, tax filings, and corporate administration, providing him with broad experience in corporate accounting and financial management. Published education: B.B.A., Business Administration, Sejong University. The primary profile’s career/background list names Igloo Corporation; undated entries are not independently verified concurrent appointments. Published areas: Asset, Accounting, Audit. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Heeyun Choi (최희윤) is published in Korea Investment Partners’ current Operations Partners directory as Assistant Manager. Heeyun is an Assistant Manager on the Global Strategy Team, where he supports offshore fund management and the global expansion of KIP’s portfolio companies. Drawing on his previous experience on the Fund Planning & Management Team, he brings a data-driven approach to fund management while helping connect KIP and its portfolio companies with opportunities in international markets. Before joining Korea Investment Partners, he worked as a manager at accelerator Kimgisa Lab, where he gained broad exposure to the venture ecosystem, with a focus on early-stage startups. Building on his experience across both fund management and the startup ecosystem, he now helps KIP and its portfolio companies identify new opportunities and expand their presence globally. Published education: B.S., Mathematics, University of Washington. The primary profile’s career/background list names Kimgisa Lab; undated entries are not independently verified concurrent appointments. Published areas: Global Expansion, Overseas Business, Fund Management. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Jeonghoon Lee (이정훈) is published in Korea Investment Partners’ current Operations Partners directory as Assistant Manager. Jeonghoon is an Assistant Manager on the Fund Planning & Management Team, where she is responsible for fund administration, regulatory reporting to the Financial Supervisory Service (FSS), and preparing proposals for institutional LPs. Her responsibilities also include LP communication across the fund lifecycle. Before joining Korea Investment Partners, she worked in fund management at Aju IB Investment. Her experience managing PEFs and venture funds, together with her work with anchor LPs, supports her current responsibilities across fund formation and ongoing administration. The primary profile’s career/background list names Aju IB Investment; undated entries are not independently verified concurrent appointments. Published areas: Fund Planning, Fund Management, Investment Management. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Beomjun Kim (김범준) is published in Korea Investment Partners’ current Operations Partners directory as Assistant Manager. Beomjun is an Assistant Manager on the Fund Planning & Management Team, where he works across the lifecycle of domestic venture funds and PEFs, from planning and formation through ongoing administration. He has supported multiple project fund formations as well as competitive and ad hoc institutional fundraising processes. Before joining Korea Investment Partners, he began his career as a fund management intern at DSC Investment and has continued to build his expertise in fund operations. He serves as a point of contact across fund management and investment teams as well as with other GPs and LPs. Published education: B.A., Economics, Chung-Ang University. The primary profile’s career/background list names DSC Investment; undated entries are not independently verified concurrent appointments. Published areas: Fund Planning, Fund Management, Investment Management. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Eunji Park (박은지) is published in Korea Investment Partners’ current Operations Partners directory as Assistant Manager. Eunji is an Assistant Manager on the General Affairs Team, where she supports workplace operations across corporate assets, IT administration, employee benefits, and other internal services essential to the firm’s operations. Her background in customer service informs a service-oriented approach to internal operations and employee support. She also uses digital tools and data to streamline administrative processes and improve operational efficiency across the organization. The primary profile’s career/background list names Korea Investment Partners; undated entries are not independently verified concurrent appointments. Published areas: General Affairs, Corporate Assets, Employee Benefits. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Urim Sohn (손우림) is published in Korea Investment Partners’ current Operations Partners directory as Manager. Urim is a Manager on the Asset Management Team, where she oversees fund accounting, asset operations, and external audit coordination. Her work focuses on maintaining the financial accuracy and liquidity management required to support the firm’s investment activities. Before joining Korea Investment Partners, she worked at accelerator BigBang Angels, where she managed angel investment funds and planned and operated startup support initiatives, including incubation and TIPS programs. Her experience working directly with early-stage companies provides practical context for her current responsibilities in treasury and fund accounting. The primary profile’s career/background list names BigBang Angels; undated entries are not independently verified concurrent appointments. Published areas: Asset, Fund Accounting, External Audit. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Minjung Kim (김민정) is published in Korea Investment Partners’ current Operations Partners directory as Manager. Minjung is a Manager on the Fund Planning & Management Team, where she oversees the full lifecycle of domestic venture funds, from formation and ongoing administration through dissolution and liquidation. Her responsibilities include portfolio asset administration, transaction processing, equity-related administration, and the monitoring and reporting of distressed portfolio companies. Before joining Korea Investment Partners, she began her career at MG Non-Life Insurance, where she gained experience in financial operations. She later moved to Maple Investment Partners, formerly MG Investment, and developed hands-on experience across investment and fund management activities. The primary profile’s career/background list names MG Non-Life Insurance, Maple Investment Partners; undated entries are not independently verified concurrent appointments. Published areas: Fund Planning, Fund Management, Investment Operations. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Soohyun Jeon (전수현) is published in Korea Investment Partners’ current Operations Partners directory as Manager. Soohyun is a Manager on the Fund Planning & Management Team, where he oversees internal systems, IT infrastructure, and information security. His responsibilities include ERP administration, systems availability, security controls, and the technology environment supporting the firm’s investment and corporate functions. He holds an M.S. in Physics from Dongguk University and worked at KGT Lab. Co., Ltd. before joining Korea Investment Partners. His analytical training informs a structured approach to systems and data management as well as the technical and operational issues that arise across the firm’s IT environment. Published education: M.S., Physics, Dongguk University. The primary profile’s career/background list names KGT Lab. Co., Ltd.; undated entries are not independently verified concurrent appointments. Published areas: Systems Management, IT Operations, Information Security. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Jiyeon Lee (이지연) is published in Korea Investment Partners’ current Operations Partners directory as Manager. Jiyeon is a Manager on the Corporate Management Team, where she oversees human resources, employee benefits, and corporate operations. Her responsibilities include internal policies, administrative requirements, and HR programs across the firm. Before joining Korea Investment Partners in 2013, Jiyeon worked in fund custody operations at NongHyup Bank. Since joining KIP, she has held roles across investment administration and fund treasury management, building a broad understanding of the firm’s operational functions before moving into corporate management and HR. The primary profile’s career/background list names NongHyup Bank; undated entries are not independently verified concurrent appointments. Published areas: HR, Corporate Operations, Employee Benefits. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Danny Kang (강무경) is published in Korea Investment Partners’ current Operations Partners directory as Head of Global Strategy Team. Danny leads the Global Strategy Team at Korea Investment Partners, overseeing domestic and international fundraising(LP relations), overseas fund management, strategic partnerships, and global initiatives. He is in charge of building and maintaining with new and existing LPs in Korea and global. He also supports the international expansion of portfolio companies and oversees the operations and capital formation activities of KIP’s overseas offices. Before joining Korea Investment Partners, he led open innovation at hardware accelerator N15, where he developed partnerships between startups and large corporations. That experience now informs his work connecting investors, corporates, founders, and international networks to create new investment and business opportunities. Published education: B.A., Sociology, University of Washington. The primary profile’s career/background list names N15; undated entries are not independently verified concurrent appointments. Published areas: Fundraising, Global Strategy, LP Relation. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Okhwa Baek (백옥화) is published in Korea Investment Partners’ current Operations Partners directory as Head of Asset Management Team. Okhwa is Deputy General Manager and Head of Asset Management at Korea Investment Partners, where she oversees corporate treasury, fund and PEF accounting, financial reporting, and external audit coordination. With more than a decade of experience at KIP, she has worked across a broad range of fund administration and financial operations. Her experience spans complex financial and fund-related matters across different operating environments. As head of the team, Okhwa oversees treasury operations, accounting processes, and audit readiness, with particular emphasis on accuracy, consistency, and effective financial management. The primary profile’s career/background list names Korea Investment Partners; undated entries are not independently verified concurrent appointments. Published areas: Asset Management, Fund & PEF Accounting, External Audit. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Inho Hwang (황인호) is published in Korea Investment Partners’ current Operations Partners directory as Deputy General Manager. Inho is a Deputy General Manager on the Fund Planning & Management Team, where he oversees fund planning, fund administration, and portfolio asset management. A key part of his role is validating financial data and performance metrics and providing LPs with accurate, timely information throughout the fund lifecycle. Before joining Korea Investment Partners, Inho worked at LG Hausys in financial accounting, corporate planning, and management. His background in corporate finance and planning now informs his work across fund operations, data analysis, and investor reporting. Published education: B.A., Economics, Yonsei University. The primary profile’s career/background list names LG Hausys; undated entries are not independently verified concurrent appointments. Published areas: Fund Planning, Fund Management, Investment Operations. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Deukhee Kim (김득희) is published in Korea Investment Partners’ current Operations Partners directory as Head of Financial Management Team. Deukhee is General Manager and Head of Financial Management at Korea Investment Partners, where he oversees separate and consolidated financial reporting, corporate tax, external audits, and performance reporting to the holding company. He is responsible for the financial processes that support the firm’s investment and business operations. As a Korean Certified Public Accountant, Deukhee spent five years at Samil PwC in audit and financial advisory, working across a broad range of accounting, reporting, and tax matters. Since joining Korea Investment Partners in December 2017, he has continued to strengthen the firm’s financial reporting and management processes while managing the financial and tax risks associated with its growth. Published education: B.A., Economics, Chung-Ang University. The primary profile’s career/background list names Samil PwC / KICPA; undated entries are not independently verified concurrent appointments. Published areas: Accounting, Tax, External Audit. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Wooram Yoo (유우람) is published in Korea Investment Partners’ current Operations Partners directory as Head of Corporate Management Team. Wooram is Executive Director and Head of Corporate Management at Korea Investment Partners, where he oversees corporate planning, human resources, and general affairs. As a Korean Certified Public Accountant, he brings accounting and tax expertise to a broad range of management and operational matters across the firm. Before joining Korea Investment Partners, Wooram worked in the Financial Services Group at Samil PwC, providing audit and accounting advisory services to banks, securities firms, insurance companies, and venture capital firms. His experience across the financial sector now informs his approach to corporate planning and management as KIP continues to grow. Published education: B.B.A., Business Administration, Yonsei University. The primary profile’s career/background list names Samil PwC / KICPA; undated entries are not independently verified concurrent appointments. Published areas: Business Planning, Accounting, Tax. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Hee Song (송희) is published in Korea Investment Partners’ current Operations Partners directory as Head of Fund Planning & Management Team. Hee is Executive Director and Head of Fund Planning & Management at Korea Investment Partners, where she oversees the full lifecycle of venture and private equity funds, from planning and formation through ongoing management and liquidation. She also leads from domestic institutional RFPs and proposal activities to liquidation process. With more than 18 years of experience at leading Korean venture capital firms, including LB Investment and KTB Network, she has built extensive experience across fund management, fund finance, accounting, tax, and LP relations. Drawing on her experience across a wide range of funds and operating environments, she leads domestic institutional investor communication and fund operations at KIP. The primary profile’s career/background list names LB Investment, KTB Network; undated entries are not independently verified concurrent appointments. Published areas: Fund Planning, Fund Management, Fundraising. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Hwang Kim (김황) is published in Korea Investment Partners’ current Operations Partners directory as Head of Management Support Department. Hwang is Managing Director and Head of Management Support at Korea Investment Partners, where he oversees the firm’s financial management, accounting, human resources, and corporate planning functions. He coordinates these areas across the organization to support the firm’s continued growth and investment activities. Before joining Korea Investment Partners, Hwang worked at the Venture Investment Information Center of the Korea Venture Capital Association, where he was responsible for regulatory affairs, industry statistics, and planning. This experience gave him a broad understanding of Korea’s venture capital industry, which he now applies across the firm’s management functions. Published education: B.B.A., Business Administration, University of Seoul. The primary profile’s career/background list names Korea Venture Capital Association; undated entries are not independently verified concurrent appointments. Published areas: Management Support, Financial Management, Corporate Planning. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Changho Kim (김창호) is published in Korea Investment Partners’ current Operations Partners directory as Head of Investment Support Department. Changho is Managing Director and Head of Investment Support at Korea Investment Partners, where he leads the Fund Planning & Management Team and the Global Strategy Team. He oversees the firm’s investment support functions across fund planning, formation, administration, fundraising, LP relations, and global initiatives. Before joining Korea Investment Partners, he worked on the Research Team at the Korea Venture Capital Association, where he developed a broad understanding of Korea’s venture capital industry and fund management practices. He brings that perspective to his current role overseeing fund operations, investor relations, and global activities across the Investment Support Office. Published education: B.A., Economics, Yonsei University. The primary profile’s career/background list names Korea Venture Capital Association; undated entries are not independently verified concurrent appointments. Published areas: Investment Operation, LP Relations, Fundraising. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Yongjae Kim (김용재) is published in Korea Investment Partners’ current Operations Partners directory as Head of Operation Division. Yongjae is Executive Managing Director and Head of Management Support at Korea Investment Partners, where he oversees fundraising, fund formation, LP relations, and the firm’s broader management support functions. He began his career at Korea Investment Partners in 1999 and has played a central role in developing the operating processes that have supported the firm’s growth. Since the early development of Korea’s venture capital industry, he has led a broad range of support functions at KIP. In particular, he has overseen fundraising for many years, contributing significantly to the expansion of the firm’s assets under management while building longstanding relationships with institutional investors and LPs. Published education: B.S., Marketing, University of Dubuque. The primary profile’s career/background list names Korea Investment Partners; undated entries are not independently verified concurrent appointments. Published areas: Management Support, LP Relations, Fundraising. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Hyoungsub Kim (김형섭) is published in Korea Investment Partners’ current Risk Management Partners directory as Manager. Hyoungsub is a Manager in the Risk Management Office at Korea Investment Partners, where he is responsible for risk monitoring, valuation, and financial due diligence across the firm’s funds and portfolio companies. His work includes reviewing the financial information and assumptions underlying investment and portfolio decisions. Before joining Korea Investment Partners, he worked in the Assurance practice at Samil PwC, conducting external audits across a range of companies. He also worked on valuations for financial reporting purposes and internal accounting advisory engagements, experience he now applies to portfolio risk assessment and valuation reviews at KIP. Published education: B.B.A., Business Administration, Yonsei University. The primary profile’s career/background list names Samil PwC / KICPA; undated entries are not independently verified concurrent appointments. Published areas: Risk Management, Internal Audit, Financial Due Diligence. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Yujoung Kim (김유정) is published in Korea Investment Partners’ current Risk Management Partners directory as Manager. Yujoung is a Manager in the Risk Management Office at Korea Investment Partners, where she is responsible for financial due diligence and accounting reviews across the firm’s investment portfolio. She assesses the financial condition of portfolio companies from an independent perspective and uses financial data and analysis to identify risks relevant to investment decisions. A Korean Certified Public Accountant, she worked at Samil PwC before joining Korea Investment Partners, gaining experience in external audit and financial analysis across a range of companies. Her accounting and financial expertise now informs her assessment of portfolio companies and the financial risks underlying KIP’s investments. Published education: B.A., Economics, Sungkyunkwan University. The primary profile’s career/background list names Samil PwC / KICPA; undated entries are not independently verified concurrent appointments. Published areas: Risk Management, Internal Audit, Financial Due Diligence. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Seungbeen Paik (백승빈) is published in Korea Investment Partners’ current Risk Management Partners directory as General Manager. Seungbeen is a General Manager in the Risk Management Office at Korea Investment Partners, where he leads financial due diligence and supports post-investment monitoring across the firm’s portfolio. He provides an independent perspective on the financial assumptions and evidence underlying investment decisions. As a Korean Certified Public Accountant, he spent five years at EY Han Young in audit and financial advisory. Since joining Korea Investment Partners in April 2018, he has played a key role in advancing the firm’s financial due diligence practices and has remained closely involved in assessing financial and tax risks across the portfolio. Published education: B.A., English Language and Literature, Korea University. The primary profile’s career/background list names EY Han Young / KICPA; undated entries are not independently verified concurrent appointments. Published areas: Risk Management, Internal Audit, Financial Due Diligence. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Hyunsoo Go (고현수) is published in Korea Investment Partners’ current Risk Management Partners directory as Head of Risk Management Department. Hyunsoo is a General Manager and Head of Risk Management at Korea Investment Partners, where he oversees risk across investment decisions, funds, and portfolio companies. As a Korean Certified Public Accountant, he applies his financial and accounting expertise to assessing the assumptions, valuations, and financial information underlying KIP’s investments. Before joining Korea Investment Partners in 2016, he worked in M&A advisory and valuation at Deloitte Anjin, corporate credit analysis at Korea Investors Service, and audit and consulting at Samjong KPMG. His experience across valuation, credit analysis, and audit gives him multiple perspectives from which to assess both investment potential and the risks that accompany it. Published education: B.S. Earth and Environmental Systems Engineering, Seoul National University. The primary profile’s career/background list names Deloitte Anjin / KICPA, KPMG Samjong, Korea Investors Service; undated entries are not independently verified concurrent appointments. Published areas: Risk Management, Internal Audit, Financial Due Diligence. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Sangheon Shin (신상헌) is published in Korea Investment Partners’ current Compliance Team directory as Compliance Officer / Head of Compliance Team. Sangheon is Compliance Officer, and Head of Compliance at Korea Investment Partners, where he oversees regulatory compliance, internal controls, legal advisory, and regulatory reporting. He advises the firm on legal and compliance matters across its corporate and investment activities. Before joining Korea Investment Partners, he worked in the legal departments of NAVER Corporation and Hyundai Motor Company, where his responsibilities spanned compliance, internal controls, legal advisory, and risk management. His experience across large corporate organizations now informs his work on contract review, investment-related legal matters, and regulatory requirements at KIP. Published education: B.B.A., Business Administration, Sogang University J.D., Sogang University School of Law. The primary profile’s career/background list names Naver / Attorney (Korea), Hyundai Motors; undated entries are not independently verified concurrent appointments. Published areas: Compliance, Legal Advisory, Regulatory Reporting. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Sanghwa Lee (이상화) is published in Korea Investment Partners’ current Legal Department directory as Head of Legal Department. Sanghwa is Head of Legal at Korea Investment Partners, where he oversees legal matters across the firm’s investment and corporate activities. He advises on investment agreements and other key contracts, assesses legal risks throughout the investment process, and provides counsel on matters requiring legal judgment. He studied economics at Seoul National University and earned his J.D. from Yonsei University School of Law. Before joining Korea Investment Partners, he worked at the Samsung Economic Research Institute and Dongseo Partners Law Firm. His background in both economics and law allows him to consider the commercial context of an investment alongside its legal implications. Published education: B.A., Economics, Seoul National University J.D., Yonsei University School of Law. The primary profile’s career/background list names Samsung Economic Research Institute / Attorney (Korea), Dongseo Partners Law Firm; undated entries are not independently verified concurrent appointments. Published areas: Legal, Risk Management, Due Diligence. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Giseok Park (박기석) is published in Korea Investment Partners’ current Private Equity Partners directory as Principal. Giseok is a Principal on PE Team 3 at Korea Investment Partners, where he invests across industrials, AI, and ICT. He looks across markets, technologies, and business models to identify differentiated companies with the potential to build lasting competitive advantages. Before joining Korea Investment Partners, he worked in the M&A practice at Samjong KPMG, advising on acquisitions and divestitures. He later joined the IPO Division at Mirae Asset Securities, where he sourced and invested in private companies and worked on IPO transactions, gaining experience across M&A, private investing, and capital markets. Published education: B.A., Economics, Sogang University. The primary profile’s career/background list names Samjung KPMG / KICPA, Mirae Asset Securities; undated entries are not independently verified concurrent appointments. Published areas: Industrials, AI, ICT. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

JunIk Jang (장준익) is published in Korea Investment Partners’ current Private Equity Partners directory as Principal. Junik is a Principal on PE Team 4 at Korea Investment Partners, where he focuses on investments across ICT, manufacturing, and materials, parts, and equipment. He evaluates business resilience, cash flow, transaction structure, and exit potential alongside a company’s growth prospects. He began building his investment experience through multiple private equity internships before joining DB Securities and later Truston Asset Management. His experience across the capital markets has shaped an investment approach that considers both structural growth opportunities and downside risk to invested capital. Published education: B.B.A., Business Administration, Hanyang University. The primary profile’s career/background list names DB Securities, Truston Asset Management; undated entries are not independently verified concurrent appointments. Published areas: ICT, Manufacturing, MPE. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Kilho Jeong (정길호) is published in Korea Investment Partners’ current Private Equity Partners directory as Principal. Kilho is a Principal on PE Team 1 at Korea Investment Partners, where he focuses on investments across ICT, manufacturing, and deep tech. He evaluates market structure, competitive positioning, and management execution across companies at different stages of growth. Before joining Korea Investment Partners, he worked at Kiwoom Private Equity and Shinhan Capital, executing buyout and growth capital investments and working closely with portfolio companies after investment. He joined KIP to take a more active role in long-term value creation beyond transaction execution. Published education: B.B.A., Global Business Administration, Sungkyunkwan University. The primary profile’s career/background list names Kiwoom Private Equity, Shinhan Capital; undated entries are not independently verified concurrent appointments. Published areas: ICT, Manufacturing, Deeptech. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

John MJ Kim (김민준) is published in Korea Investment Partners’ current Private Equity Partners directory as Principal. John is a Principal on PE Team 2 at Korea Investment Partners, where he focuses on growth investments across TMT, ESG, and deep tech. He evaluates emerging market opportunities created by technology while considering business models, competitive positioning, and financial fundamentals. Before joining Korea Investment Partners in 2020, John worked at Kiwoom Private Equity, where he executed growth investments across software, manufacturing, and other industries. His academic background spans food and resource economics and an interdisciplinary program in software technology and entrepreneurship at Korea University, and he is also a U.S. Certified Public Accountant. Published education: B.A., Food and Resource Economics & Software and Venture Engineering, Korea University. The primary profile’s career/background list names Kiwoom Private Equity / U.S. CPA; undated entries are not independently verified concurrent appointments. Published areas: TMT, ESG, DeepTech. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Junyoung Baek (백준영) is published in Korea Investment Partners’ current Private Equity Partners directory as Director. Junyoung is a Director on PE Team 1 at Korea Investment Partners, where he focuses on technology-driven investments across AI, robotics, and ICT. He evaluates business models, industry structure, competitive positioning, and potential paths to scale when assessing investment opportunities. He began his career at Hyundai Samho Heavy Industries, gaining firsthand experience in manufacturing operations, and later worked on IPO transactions at Kyobo Securities. He subsequently continued his career in investment management, including at History Investment Advisory, building a perspective that combines operating businesses with capital markets and investing. Published education: B.B.A., Business Administration, University of Seoul M.B.A., Fudan University (Dual Degree with Korea University). The primary profile’s career/background list names HD Hyundai Samho, Kyobo Securities, History Investment Advisory; undated entries are not independently verified concurrent appointments. Published areas: AI, Robotics, ICT. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Youngtak Lee (이영탁) is published in Korea Investment Partners’ current Private Equity Partners directory as Head of PE Team 4. Youngtak is a Director on PE Team 4 at Korea Investment Partners, where he invests across ICT, manufacturing, and materials, parts, and equipment through transaction structures including buyouts and mezzanine investments. He considers broader industry dynamics and structural market growth alongside company-specific fundamentals. Before joining Korea Investment Partners, he spent several years in Deal Advisory at Samjong KPMG and Deloitte Anjin, working on transaction structuring and execution across a range of industries. His experience analyzing financial profiles and competitive positioning led him to move from advisory to the buy-side and take direct responsibility for investment decisions. Published education: B.B.A., Business Administration, Yonsei University. The primary profile’s career/background list names Deloitte Anjin / KICPA, KPMG Samjong; undated entries are not independently verified concurrent appointments. Published areas: ICT, Manufacturing, MPE. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Taewoo Nam (남태우) is published in Korea Investment Partners’ current Private Equity Partners directory as Head of PE Team 3. Taewoo is Head of PE Team 3 at Korea Investment Partners, where he leads growth equity, significant minority, and buyout investments with a particular focus on the global competitiveness of Korean manufacturing and industrial companies. His investment experience includes Air Zeta, Chips&Media, and Oasis, together with board participation at portfolio companies. He has approximately 18 years of investment experience spanning both LP and GP roles. At the Public Officials Benefit Association, he managed domestic and international private equity portfolios, selected fund managers, and participated in co-investments. He joined Korea Investment Partners in 2019 to become more directly involved in investment decisions and portfolio company growth, and now brings both LP and GP perspectives to his investment approach. Published education: B.A., Economics and Public Administration, Hanyang University M.B.A., National University of Singapore. The primary profile’s career/background list names Public Officials Benefit Association (POBA), Alpha Asset Management, Daishin Securities, Opeaz Investment, Axis Investment, CNK Investment, History Investment Advisory; undated entries are not independently verified concurrent appointments. Published areas: ICT, Manufacturing, Materials. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Sangjoon Park (박상준) is published in Korea Investment Partners’ current Private Equity Partners directory as Head of PE Team 2. Sangjoon is Head of PE Team 2 at Korea Investment Partners, where he focuses on growth capital investments across energy and infrastructure, AI and robotics, and ICT services. He evaluates opportunities based on management execution, global scalability, market growth, and future potential that may not yet be fully reflected in a company’s current valuation. Before moving into private equity and venture capital, Sangjoon worked at Monitor Group Korea and GS Holdings in corporate strategy and portfolio management. He joined Korea Investment Partners as a founding member of the PE Division and has since contributed to growing the division’s assets under management to more than KRW 1 trillion and expanding its portfolio across a broader range of sectors and growth stages. Published education: B.B.A., Business Administration, Yonsei University. The primary profile’s career/background list names GS Holdings, Monitor Group Korea; undated entries are not independently verified concurrent appointments. Published areas: IT, Energy, Resources. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Haksung Chang (장학성) is published in Korea Investment Partners’ current Private Equity Partners directory as Head of PE Division. Haksung is Head of the PE Division at Korea Investment Partners, where he leads the division’s investment strategy across IT, consumer, and manufacturing. He evaluates investment opportunities across company fundamentals, industry structure, transaction design, and downside risk. His notable investments include E-Land Retail, Carelabs, and Revu Corporation. Before joining Korea Investment Partners, Haksung worked at Eugene Asset Management, Macquarie International Ltd., and Samil PwC, building experience across asset management, investing, accounting, and finance. This background informs an investment approach that considers individual companies alongside broader industry structures and capital market conditions. Published education: B.A., Economics, Seoul National University. The primary profile’s career/background list names Samil PwC / KICPA, Macquarie International Ltd, Eugene Asset Management; undated entries are not independently verified concurrent appointments. Published areas: IT, Consumer, Manufacturing. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Soohyun Lee (이수현) is published in Korea Investment Partners’ current Venture Partners directory as Associate. Soohyun built her career scaling services across diverse categories, launching and growing a global platform at SNOW, leading the early-stage growth of Karrot’s Canadian business, and helping scale a global webtoon platform at RIDI. She transitioned into venture capital to create broader impact at the industry level beyond the growth of individual products. She invests in early- and growth-stage companies across content and IT services, evaluating opportunities based on team differentiation and execution, market potential, and scalability. She closely follows evolving user behavior and industry dynamics within the content ecosystem, with a particular interest in teams that can demonstrate tangible growth in the market. Outside of investing, she stays connected with industry practitioners and explores emerging content and cultural trends through performances and travel. Published education: B.B.A., Business Administration / B.A., Information Science and Culture, Seoul National University. The primary profile’s career/background list names SNOW Corporation, Danggeun Market (Karrot), RIDI Corporation; undated entries are not independently verified concurrent appointments. Published areas: Media, Contents, Entertainment. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Jiyun Kim (김지윤) is published in Korea Investment Partners’ current Venture Partners directory as Principal. Jiyun has built her career across accelerators, CVCs, and securities firms, including Sunbo Angel Partners, Musinsa Partners, and KakaoPay Securities, gaining exposure to companies at various stages of growth. This breadth of experience has shaped how she evaluates founders and companies through the lens of both markets and capital. She invests across consumer, IT, and deep tech, focusing on fundamentals and execution over narrative. She believes in the ability of ambitious founders and differentiated technology to create meaningful change, and aims to be more than a capital provider by supporting teams as they turn potential into scalable businesses. Published education: B.A., International Studies and Venture Management, Ewha Womans University. The primary profile’s career/background list names Sunbo Angel Partners, Musinsa Partners, KakaoPay Securities; undated entries are not independently verified concurrent appointments. Published areas: ICT, Consumer, Deeptech. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Soonoh Ga (가순오) is published in Korea Investment Partners’ current Venture Partners directory as Principal. Soonoh began his career in the Strategy & Planning Division at SK Bioscience. He then spent five years in the IPO divisions of Daishin Securities and KB Securities, working on listings including Kakao Pay, HD Hyundai Marine Solution, Doosan Robotics, Jeju Beer, and Sandoll. His hands-on experience guiding companies through the IPO process led him to venture capital, where he could become involved earlier in their growth. Having worked with companies across the journey from early growth to IPO, Soonoh approaches the challenges facing startups through a capital markets lens. He favors companies with differentiated competitive advantages in industries undergoing structural change and invests across deep tech, mobility, and ICT platforms from Series A through Pre-IPO. His capital markets experience is particularly relevant to growth-stage companies preparing for a future listing. Published education: B.Sc., International Management, University of Manchester. The primary profile’s career/background list names SK Bioscience, Daishin Securities, KB Securities; undated entries are not independently verified concurrent appointments. Published areas: DeepTech, Mobility, ICT. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Ellie Dongwon Sung (성동원) is published in Korea Investment Partners’ current Venture Partners directory as Principal. Ellie began her career as a Data Scientist at SK hynix and later worked as an AI Research Fellow at SK Innovation, gaining hands-on experience applying data and AI to solve problems in the semiconductor and energy industries. She transitioned into venture capital to take a more direct role in bringing new technologies to market and supporting their growth. She focuses on emerging technologies including AI and the teams building new markets around them. With practical experience in semiconductors and AI, Ellie evaluates both the technical feasibility and scalability of emerging technologies and works closely with promising teams as they build and grow their businesses. Published education: B.S., Statistics and Economics, University of Illinois at Urbana-Champaign. The primary profile’s career/background list names SK Innovation, SK Hynix; undated entries are not independently verified concurrent appointments. Published areas: AI, DeepTech, Quantum. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Junseok Oh (오준석) is published in Korea Investment Partners’ current Venture Partners directory as Principal. Junseok began his career at NH Investment & Securities, where he worked across equity research and IPOs. His experience advising companies as they prepared to go public gave him direct exposure to their growth and development, and ultimately led him to venture capital, where he could engage with companies at an earlier stage. He focuses on semiconductors, IT components and materials, and industrial automation—sectors where deep technical capabilities form the foundation of competitiveness. Rather than focusing on near-term performance alone, Junseok looks for companies with structural and sustainable competitive advantages and core capabilities that can strengthen and compound over time. Published education: B.B.A., Business Administration, Sungkyunkwan University. The primary profile’s career/background list names NH Investment & Securities, Samsung Securities; undated entries are not independently verified concurrent appointments. Published areas: IT Convergence, MPE, Semiconductor. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Jihyun Ahn (안지현) is published in Korea Investment Partners’ current Venture Partners directory as Principal. Jihyun studied biological sciences with a strong interest in how science and technology can translate into real-world impact. She later worked at the Ministry of Science and ICT, where she was involved in science and technology policy planning and R&D programs in pharmaceuticals and precision medicine. Her interest in working closer to the commercialization of emerging technologies eventually led her to venture capital. With a background in biology, Jihyun primarily invests in bio and healthcare while also exploring opportunities across AI, robotics, content, and other technology-driven sectors. She looks for teams that can identify fundamental problems, develop effective solutions, and respond quickly to market feedback while navigating uncertainty. Published education: B.S., Biological Sciences, Seoul National University. The primary profile’s career/background list names Aju IB Investment, Ministry of Science and ICT; undated entries are not independently verified concurrent appointments. Published areas: Bio, Healthcare, Pharma. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Stephanie Seunghi Kang (강승희) is published in Korea Investment Partners’ current Venture Partners directory as Director. Stephanie spent seven years at Samsung Life Insurance, where she worked across overseas bond investments, international private equity investments, and investor relations. Her interest in working more closely with companies as they grow led her to join Korea Investment Partners in 2011, where she has since invested across a broad range of sectors. Stephanie approaches investing with a strong curiosity for new ideas and unfamiliar perspectives, an outlook she also carries into her travels and experiences outside of work. She values founders and teams that can create a positive impact and makes a conscious effort to avoid becoming too narrow in how she views markets and industries. More recently, she has found herself thinking deeply about how to raise children in a rapidly changing world, a question that also influences how she considers the future of industries and businesses. Published education: B.A., Political Science and International Relations, Korea University. The primary profile’s career/background list names Samsung Life Insurance; undated entries are not independently verified concurrent appointments. Published areas: IT, Media, Contents. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Heejin Kim (김희진) is published in Korea Investment Partners’ current Venture Partners directory as Executive Director. Heejin began his career as a semiconductor engineer at Samsung Electronics before moving to Partners Investment, where he gained investment experience and witnessed firsthand how technology and capital can come together to reshape industries. Rather than following a more predictable path, he was drawn to venture capital by the opportunity to work alongside founders creating new value amid uncertainty. He looks for founders with ambitions beyond building unicorns toward creating the next generation of decacorns, and takes a people-first approach to investing from the earliest stages. He focuses on the vision and execution of founding teams, as well as their potential to reshape markets at a structural level, and strives to be a long-term partner who listens closely to the voices of founders. Beyond investing, he also hopes to one day create something in his own way that resonates with people. Published education: B.S., Advanced Materials Science and Engineering, Korea University. The primary profile’s career/background list names Samsung Electronics, Partners Investment; undated entries are not independently verified concurrent appointments. Published areas: IT, Mobile, Semiconductor. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Eunjae Jung (정은재) is published in Korea Investment Partners’ current Venture Partners directory as Executive Director. Eunjae developed a deep understanding of pharmaceutical and biopharmaceutical technologies through academic research and hands-on experience at Chong Kun Dang’s DDS laboratory. His interest gradually expanded from the science itself to how new technologies can be developed into viable products and businesses, which led him to venture capital. He invests across stages in bio and healthcare, with a focus on the competitiveness of core technologies and their potential for commercialization. Eunjae is particularly interested in companies that can bridge the gap between scientific innovation and the market, turning promising research into products and businesses with real-world relevance. Published education: Ph.D., Pharmacy, Seoul National University. The primary profile’s career/background list names Chong Kun Dang Pharmaceutical / Pharmacist; undated entries are not independently verified concurrent appointments. Published areas: Bio, Healthcare, Pharma. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Jisoo Lee (이지수) is published in Korea Investment Partners’ current Venture Partners directory as Executive Director. Jisoo began her venture capital career at Michigan Venture Capital, driven by a desire to contribute to the growth of the content industry through investment rather than as a creator herself. She later joined Magna Investment before moving to Korea Investment Partners, where she now leads the firm’s content investments as the lead fund manager of the "Korea Investment Global Content Fund" I and II. She focuses on identifying IP and creative teams with the potential to compete in global markets and supporting the international expansion of K-content. Jisoo places particular emphasis on the passion, commitment, and execution capabilities of management teams, and favors companies pursuing new ideas and strategies rather than simply repeating established formulas. Published education: B.A., Geography, Seoul National University B.A., Psychology, Oberlin College. The primary profile’s career/background list names ePNIC / Infineon Technologies, Michigan Venture Capital, Magna Investment; undated entries are not independently verified concurrent appointments. Published areas: Media, Contents, Entertainment. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Michael Kyowook Lee (이교욱) is published in Korea Investment Partners’ current Venture Partners directory as Executive Director. Michael began his career as a software engineer at Microsoft, where he contributed to the development of Windows Live ID. He later co-founded mobile gaming startup Loadcomplete and served as CIO, leading the company’s technology organization and product development. He then joined Samsung Electronics, where he worked in product and business strategy and gained experience bringing technology into products and markets. These experiences ultimately led him to venture capital. Michael invests across early- and growth-stage companies, with a particular focus on robotics and AI. He looks for opportunities where differentiated technologies can open new markets or reshape existing industries, and focuses on teams with strong technical capabilities and the execution needed to scale. He works closely with founders who can continue building durable competitive advantages as technologies and markets evolve. Published education: M.S., Computer Science, Case Western Reserve University M.B.A., Columbia Business School. The primary profile’s career/background list names Microsoft, Loadcomplete, Samsung Electronics; undated entries are not independently verified concurrent appointments. Published areas: IT, AI, Game. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Hangil Son (손한길) is published in Korea Investment Partners’ current Venture Partners directory as Executive Director. Hangil has a scientific background in cell biology and pharmacology and gained hands-on clinical development experience at Hanmi Pharmaceutical, where he worked across the scientific and clinical aspects of drug development. He moved into venture capital to take a more direct role in the commercialization of innovative technologies and has since built a portfolio spanning multiple drug modalities and aesthetic healthcare. Hangil invests across stages from early to growth, with a focus on bio and healthcare, aesthetics, and general-purpose AI platforms. His experience in pharmacology and clinical development informs his evaluation of emerging technologies, including novel mechanisms of action, longevity, and AI integration. He focuses on companies with strong scientific foundations and the potential to lead meaningful technological shifts. Published education: Ph.D., Cell Biology / Pharmacology, Yonsei University. The primary profile’s career/background list names Hanmi Pharmaceutical; undated entries are not independently verified concurrent appointments. Published areas: Bio, Healthcare, Pharma. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Jihoon Jung (정지훈) is published in Korea Investment Partners’ current Venture Partners directory as Executive Director. Jihoon has a background in biotechnology and worked in clinical and medical affairs at Novartis, where he gained firsthand experience in how innovative technologies are brought into clinical practice. He joined Korea Investment Partners to take a more direct role in turning scientific potential into viable businesses and now focuses on identifying innovative companies across bio, healthcare, and AI. Jihoon primarily invests in Series A–B companies, evaluating opportunities based on the scientific validity of core technologies, the expertise and execution capabilities of founding teams, and the clarity of their go-to-market strategies. Beyond providing capital, he works closely with companies to help translate strong R&D capabilities into sustainable commercial growth. Published education: Ph.D., Biotechnology, Yonsei University. The primary profile’s career/background list names Novartis Korea; undated entries are not independently verified concurrent appointments. Published areas: Bio, Healthcare, Pharma. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Soonouk Jung (정순욱) is published in Korea Investment Partners’ current Venture Partners directory as Executive Director. Soonouk brings a multidisciplinary perspective across technology, business, and law, supported by his engineering background and qualification as a patent attorney. Working closely with Korea Investment Partners’ U.S. office, he has been involved in cross-border deal sourcing in Silicon Valley, connecting Korean institutional capital with the global venture ecosystem. This experience has deepened his understanding of technical barriers to entry and structural competitive advantages, while strengthening his interest in the commercialization of emerging technologies. Soonouk evaluates investment opportunities based on technical barriers to entry, structural competitive advantages, global scalability, and the domain expertise and execution capabilities of founders. Rather than following market trends, he focuses on a more fundamental question: "Why this team, with this technology architecture, can build a lasting advantage in this market at this point in time" Published education: B.S., Chemical and Biological Engineering, Seoul National University M.S., Management, KAIST LL.M., Northwestern University Pritzker School of Law. The primary profile’s career/background list names Industrial Bank of Korea / Patent Attorney, Jungang Law Firm, Melfas; undated entries are not independently verified concurrent appointments. Published areas: AI, Healthcare, IT Service. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Donghyun Song (송동현) is published in Korea Investment Partners’ current Venture Partners directory as Executive Director. Donghyun began his career as an engineer, working as a researcher at KIST and later as a principal researcher at Samsung Display. With a background in materials science and engineering, he transitioned into venture capital to work more closely with companies that can make a tangible contribution to industry and to participate in their growth over the long term. He focuses on deep tech and materials, parts, and equipment, evaluating companies based on the structural competitiveness of their technologies and their potential impact on industry. Donghyun pays particular attention to teams tackling problems that remain unsolved and to whether their technologies can translate into meaningful value in real industrial applications. Published education: Ph.D., Materials Science and Engineering, Seoul National University. The primary profile’s career/background list names Korea Institute of Science and Technology (KIST), Samsung Display; undated entries are not independently verified concurrent appointments. Published areas: IT, MPE, Materials. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Hwamok Chung (정화목) is published in Korea Investment Partners’ current Venture Partners directory as Managing Director. Hwamok built his career across Hyundai Commercial and the LG Foundation, gaining experience across both finance and the nonprofit sector. His exposure to different organizations and industries has shaped a broad perspective on markets, consumers, and emerging trends, which he now applies to venture investments across IT, AI, consumer, and content. He focuses on investing in founders and entrepreneurs who are working to improve people's lives today or just ahead of the curve, shift existing industry problems in a positive direction or expand into new industries, and capture the spirit of the times through IP and content. Published education: B.B.A., Business Management, Yonsei University M.B.A., Seoul National University. The primary profile’s career/background list names Hyundai Commercial, LG Foundation; undated entries are not independently verified concurrent appointments. Published areas: Contents, Consumer, IT Service. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Kunho Kim (김근호) is published in Korea Investment Partners’ current Venture Partners directory as Managing Director. Kunho spent six years at Samil PwC, working across audit and deal advisory and developing a deep understanding of corporate financials and business structures. His interest gradually shifted from analyzing past performance to working more closely with companies as they build future growth and innovation, leading him to transition into venture capital. He focuses on growth-stage investments in technology-driven companies with clear differentiation, evaluating scalability and competitive positioning as key factors. Beyond the initial investment, Kunho works closely with portfolio companies on their growth and potential exit pathways, including IPOs and M&A. Published education: B.A., Economics, Seoul National University. The primary profile’s career/background list names Samil PwC / KICPA; undated entries are not independently verified concurrent appointments. Published areas: IT Service, IT Convergence, Consumer. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Sujin Kim (김수진) is published in Korea Investment Partners’ current Venture Partners directory as Managing Director. Sujin began her career in the gaming and content industry at NCSOFT before moving into venture capital. Her hands-on operating experience gives her a practical perspective on identifying and supporting companies with strong growth potential across content, software, and gaming. She focuses on businesses where technology and intellectual property can create new opportunities for scale, particularly across content and gaming. Sujin looks for teams with strong execution capabilities and a clear path to commercialization, with a focus on how content and technology can build lasting value in the market. Published education: M.B.A., Business Administration, Ewha Womans University. The primary profile’s career/background list names EK Communication, NC Soft, SK imedia, GSP, YD Online, Neowiz Games; undated entries are not independently verified concurrent appointments. Published areas: Contents, Software, Game. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Min Q Kim (김민규) is published in Korea Investment Partners’ current Venture Partners directory as Managing Director. Min Q began his career in control and instrumentation engineering, building hands-on experience in developing and commercializing advanced technologies. At SoftDSP, he developed a USB-based 5 GS/s PC oscilloscope that was exported to more than 10 countries. He later worked as a Senior Researcher at Samsung Electronics and the Samsung Advanced Institute of Technology, where he focused on ultra-low-power wireless communication technologies and registered more than 15 patents. His experience taking technologies from development through commercialization and into global markets led him to venture capital. He focuses on strategic deep-tech investments across quantum computing, blockchain and Web3, energy, and other emerging technology sectors, with investment experience in the U.S. and Israel. Combining 18 years of venture investing with an engineering background, he evaluates both the technical foundations and commercialization potential of emerging technologies and looks for core technologies capable of driving structural change across industries. Published education: Ph.D. Candidate, Electrical and Computer Engineering, Seoul National University. The primary profile’s career/background list names SoftDSP, Samsung Advanced Institute of Technology, Samsung Electronics; undated entries are not independently verified concurrent appointments. Published areas: AI, Deep Tech, Quantum. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Yeongmok Gil (길영목) is published in Korea Investment Partners’ current Venture Partners directory as Managing Director. Yeongmok has built an unconventional career spanning equity research, fund management, consulting, and investor relations and disclosure at listed companies. This breadth of experience gives him a differentiated perspective on both identifying investment opportunities and structuring exits. He has led investments across biotechnology, secondary transactions, and mezzanine deals involving listed companies. He primarily invests from Series B onward and takes a sector-agnostic approach. Guided by the belief that great companies are built by great management teams, he places particular emphasis on the quality of management and the soundness of their decision-making. He also identifies more closely with Charlie Munger’s philosophy of sharp, disciplined thinking behind the scenes than with Warren Buffett’s more publicly visible optimism, and brings that perspective into his investment decisions. Published education: B.S., Biochemical Engineering, KyungHee University. The primary profile’s career/background list names FnGuide, Herb Doctor International, Bio Partners, Prodizen, CKD Venture Investment; undated entries are not independently verified concurrent appointments. Published areas: Bio, Consumer, Secondary. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Deokjun Shin (신덕준) is published in Korea Investment Partners’ current Venture Partners directory as Investment Advisory. Deokjun began his career at Samsung Electronics’ Semiconductor Memory Division, where he worked on the design and development of flash memory circuits. He entered the venture capital industry in 1999 and has since focused primarily on investments in semiconductors, IT, and related technology sectors. Since joining Korea Investment Partners in 2006, he has invested in companies including Haesung Optics, Chips&Media, BOS Semiconductors, and FuriosaAI. Deokjun primarily focuses on early-stage technology companies and actively pursues co-investments in ventures with strong technical capabilities and clear technology roadmaps. Published education: M.S., Electronic Engineering, Sogang University. The primary profile’s career/background list names Samsung Electronics, KTB Network, VirtualDime, Hallym Ventures, Hanwha Investment; undated entries are not independently verified concurrent appointments. Published areas: IT, Semiconductors, Medical Devices. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Jin Huh (허진) is published in Korea Investment Partners’ current Venture Partners directory as Head of Investment Division 1. Jin built his experience in corporate analysis at Samil PwC and KB Asset Management, developing a strong understanding of financial statements, business fundamentals, and growth companies. As a Korean Certified Public Accountant, he brings a disciplined analytical perspective to investing, with a focus on companies operating in attractive markets and demonstrating clear competitive differentiation. Jin primarily invests in mid- to late-stage companies across materials, parts and equipment, and consumer sectors. His notable investments include Nextin, CMTX, NB Motion, Cafe24, and Millie’s Library. He evaluates opportunities based on market growth potential as well as the technological and business advantages that differentiate a company from its competitors. Published education: B.B.A., Business Administration, Chung-Ang University. The primary profile’s career/background list names Samil PwC / KICPA, KB Asset Management; undated entries are not independently verified concurrent appointments. Published areas: IT Convergence, MPE, Contents. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Minsik Park (박민식) is published in Korea Investment Partners’ current Venture Partners directory as Head of Investment Division 2. Minsik began his career at Daewoo Electronics after studying Business Administration at Korea University, where he gained firsthand exposure to consumer markets and the manufacturing industry. He later built his investment career at Mirae Asset Venture Investment and Mirae Asset Securities, focusing on internet, mobile, and consumer sectors. His interest in identifying innovative companies and supporting their growth in a rapidly evolving digital consumer landscape led him to join Korea Investment Partners. As Head of Investment Group 2, he oversees both domestic and international investments at KIP. He also serves as Global Head, leading the firm’s overseas investment activities and broader global investment strategy. Drawing on extensive fund management experience, he serves as Lead Fund Manager of KIP’s National Growth Fund, its 2026 flagship fund, and plays a central role in KIP’s evolution into a global venture capital firm through its domestic and international investment activities. Published education: B.A., International Trade, Korea University. The primary profile’s career/background list names Daewoo Electronics, MiraeAsset Ventures, MiraeAsset Securities; undated entries are not independently verified concurrent appointments. Published areas: IT, Mobile, Consumer. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Dongyeob Kim (김동엽) is published in Korea Investment Partners’ current Management Executives directory as CIO. Dongyeob earned his bachelor's degree in Literature from Seoul National University, and chose Korea Investment Partners as his first career step, entering the world of venture capital early on. Drawing on the broad perspective and critical thinking cultivated through his literary background, he has built deep investment expertise spanning diverse industries — including TMT, biotech, and gaming. Having grown alongside a single organization over many years, he has established himself as the leader who most fully embodies KIP's investment philosophy and culture. Building on a strong track record of successful investments, he currently serves as the Lead Fund Manager of Korea Investment Partners' flagship funds, consistently delivering outstanding fund performance through his professional expertise in fund management. In particular, he has pioneered a wide range of investment strategies — from early-stage investing to mezzanine investments in listed companies — and now leverages this experience to lead Korea Investment Partners' diversified investment strategy. Published education: B.A., German Language and Literature, Seoul National University. The primary profile’s career/background list names Korea Investment Partners; undated entries are not independently verified concurrent appointments. Published areas: Consumer, Mobile, Contents. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Mahnsoon Hwang (황만순) is published in Korea Investment Partners’ current Management Executives directory as CEO. Mahnsoon earned his bachelor's and master's degrees in Pharmacy from Seoul National University, then began his career as an R&D researcher at Yuhan Corporation. He went on to serve as Vice President at both Yuhan Corporation and ChemOn, building deep expertise in biotech and healthcare through hands-on experience ranging from new pipeline development to clinical-stage trials. Drawing on this industry background, he recognized greater potential in the role of a venture capitalist — supporting promising biotech companies with capital and strategy to help them grow. This realization led him to Korea Bio Technology Investment, and subsequently to Korea Investment Partners, which he joined in 2009. A veteran investor with a track record spanning investments in promising biotech companies both in Korea and abroad, he has experience seeing portfolio companies through to IPOs and M&A exits not only domestically but internationally as well, and currently manages a cumulative fund of over KRW 700 billion. As both a VC investor and a leader in Korea's biotech industry, he is active across a wide range of initiatives — achievements for which he received a Presidential Citation in 2025. Published education: M.S., Pharmacy, Seoul National University. The primary profile’s career/background list names Yuhan Corporation, Korea BioTechnology Investment, CHEMON, Affiliated Professor for Ewha Womans Univ. Medical Center(Clinical Trials), Chairman of New Industry Organization for Investment, Member of K ARPA-H; undated entries are not independently verified concurrent appointments. Published areas: Bio, Healthcare, Pharma. The role is a scoped firm/regional-platform affiliation; no personal portfolio checks or separate employer at each portfolio company is inferred.

Rickard Arvidsson supervised a company-linked master’s project evaluating hazards of organic flow-battery molecules using QSAR machine-learning models. Rivus identifies him as an associate professor in Environmental Systems Analysis at Chalmers. This is an external study affiliation, not employment or governance.

Arsema Andemariam joined Rivus for a master’s thesis supporting lab testing and research, as announced in April 2025. The issuer identifies her as a chemical engineer studying materials chemistry at Chalmers. No current employment or thesis end date is inferred.

Lisa Åkerlund was announced as Rivus’ Chief Technology Officer in February 2024. She earned a doctorate researching organic batteries at Uppsala and has battery-industry, project-management and sustainability experience. She is absent from the current named management directory; no departure date is inferred.

Pekka Peljo advises Rivus on technology. The issuer describes his materials-engineering research at the University of Turku, specializing in energy storage and flow batteries.

Johan Hjelm advises Rivus on technology. The issuer identifies him as a professor and section head in energy conversion and storage at the Technical University of Denmark.

Sara Hjortmar advises Rivus on business. The issuer describes her investment and asset-management work at EIT InnoEnergy and commercial experience in startups and scaleups.

Henrik Sundén advises Rivus on technology and scientific chemistry. He is a University of Gothenburg chemistry professor researching methods for making organic molecules and chemical bonds.

Niclas Davidsson is a Rivus board member with engineering and business-development experience. The issuer describes him as Meva Energy’s CEO and an industrial-engineering graduate.

Johan Söderbom is a Rivus board member. The issuer describes his energy-storage investment and research experience, including a thematic-leader role at EIT InnoEnergy and engineering-physics training.

Lars Ulin chairs Rivus’ board. The issuer identifies him as owner and managing director of NAVCAP, investing in Swedish industrial businesses and startups.

Narendiran Raveendiran works on battery building, testing and reporting at Rivus. He holds a joint renewable-energy engineering master’s from KTH and UPC, and researched electrolyte pH and stability in his company thesis. A February 2026 issuer announcement described his move from thesis and internship work into a full-time Lab Engineer role; the current directory uses Lab Technician.

Robert Scholem supports Rivus’ laboratory operations and holds a master’s degree in renewable energy engineering.

Tamara Church works on scaling Rivus’ electrolyte synthesis from laboratory and prototype results to reliable industrial processes. She earned an organic-chemistry doctorate at Cornell and has worked in academic chemistry, carbon-capture research and pharmaceutical process chemistry, including Cambrex.

Viktor Gueskine is Rivus’ Lead Scientist, contributing four decades of chemistry and research-and-development experience to its battery program.

Eduardo Maurina Morais leads Rivus’ research and development. He trained in chemistry in Brazil and earned a materials-science doctorate at Chalmers, researching ionic liquids. He helped build the company’s laboratories, testing capabilities and chemistry team after joining in January 2024.

Andreas Kölling co-founded Rivus and leads operations. An MBA graduate with management, sales and strategy experience, he joined the commercialization effort in early 2023.

Cedrik Wiberg founded Rivus and leads its battery technology and business. He earned a doctorate in electrochemistry at Chalmers and conducted postdoctoral work at the Technical University of Denmark and the University of Turku. His organic flow-battery research began in 2016.

Cindy Warner leads Novarna’s operations, finance and commercial execution. Her published background spans technology and consulting at FedEx, EY, PwC, IBM and Salesforce, and founding 360ofme.

Joe DeAngelo advises Novarna on scientific strategy and circular RNA therapeutics. His published background includes founding Apex Bioscience, development leadership at Curacyte and former leadership of Neochromosome. Earlier CircNova publications identify him as chief scientific officer.

Alex Wesselhoeft leads Novarna’s RNA research. He developed RNA circularization technology during his MIT doctoral work and co-founded ORNA Therapeutics. The company publishes his Mass General Brigham RNA core and Harvard Medical School teaching background.

Crystal Brown leads Novarna’s strategy, partnerships and fundraising. She previously worked in operations at automotive and finance companies, served as business operations director at Ocuphire Pharma and co-founded Great Lakes Biologics.

Denise Kiley joined Omega as an Executive Assistant in 2023, supporting Bernard Davitian and Michelle Doig. Her experience includes operating a small business and 15 years at State Street. She holds a Bridgewater State education degree.

Estelle Decosterd has worked as an Omega Executive Assistant in Geneva since 2018. Her previous experience includes NeoMed, Kellogg and Procter & Gamble. She trained in business at Lycee Jean-Piaget.

Susana Carella joined Omega as an Executive Assistant in 2025, supporting Otello Stampacchia. Her previous experience includes GALY, Atlas and Thomas H. Lee Partners. She holds a Boston University psychology graduate degree and a Montclair undergraduate degree.

Heather Weekley joined Omega in 2018 and is Operations Manager. She previously worked at Horizons for Homeless Children and holds public-administration and political-science qualifications from Bridgewater State.

Lindsay Shean joined Omega as an Operations Coordinator in 2024 after working in real-estate financial operations. She studied economics and psychology at Boston College.

Mark Russell joined Omega in 2010 and serves as Chief Compliance Officer and Vice President of Finance. His earlier career included Schooner and Bisys. He holds a Plymouth State degree and a Suffolk MBA.

Tara Kelly joined Omega as Senior Finance Manager in 2026 after serving alternative-investment clients at PwC. She holds a Northeastern business degree and is a certified public accountant.

Brent Jiang joined Omega as Vice President of Investor Relations in 2025 after working at Wellington. He holds a Boston University business degree and an MIT MBA.

Jonathan Hempton joined Omega as Deputy General Counsel in 2025 after corporate-transaction work at Ropes & Gray. He holds an NYU law degree, a Fletcher international-affairs degree and a Boston University business degree.

Kaitlyn Hagins joined Omega as an Operations Assistant in 2026. She studied business at Northeastern with concentrations in finance and international business.

Gilchrist DiPrete returned to Omega in 2023 as Director of Investor and Portfolio Analytics after serving as Assistant Controller from 2018 to 2022. His earlier experience includes Clean Energy Ventures, PwC, Benefit Street and Vista. He holds University of Rhode Island degrees.

Philipp Bliedung joined Omega in 2018 and is Corporate Controller. He previously worked at a family office and PwC. His degrees include Furman undergraduate study and Northeastern accounting and business graduate qualifications.

Sanjaya Singh joined Omega as a Venture Partner in June 2023. His biotechnology career includes Janssen, Boehringer Ingelheim and Tanox, and cofounding Aliada Therapeutics. He holds a Banaras Hindu University doctorate and completed postdoctoral research at MD Anderson.

Menelas Pangalos joined Omega as a Venture Partner in 2024. He led research and development at AstraZeneca from 2010 to 2024 after roles at Wyeth and GSK. His published biography describes academic and biotechnology board affiliations and his 2019 knighthood.

Maria Koehler joined Omega as a Venture Partner in 2025. An oncology physician-scientist, she previously served as Chief Medical Officer of Repare from 2019 to March 2025 and held roles at Bicycle, Pfizer, AstraZeneca and GSK. She earned medical and doctoral degrees at Silesian Medical University.

Roshawn Blunt joined Omega as a Venture Partner in 2023. She is president of Corsaire and previously worked at 1798 Consultants, Amgen, Johnson & Johnson and Boston Consulting Group. She studied at Princeton and Kellogg.

Vincent Ossipow joined Omega as a Partner in 2014 after investment roles at NeoMed, Sectoral Asset Management and Pictet. His background combines molecular biology and computational science, including a University of Geneva doctorate. His published biography identifies an Anaconda Biomed board-observer affiliation.

Kurt Kongtong Gallagher joined Omega as an Associate in 2026. His previous experience includes venture fellowships and Harvard technology transfer. He holds a Harvard immunology doctorate and a Columbia undergraduate degree.

Noelle Hutchins joined Omega in 2020 and is a Principal focused on oncology and inflammatory diseases. Her previous experience included the American Heart Association, consulting and Pipeline Angels. She holds a Brown immunology doctorate and completed postdoctoral work at UT Southwestern.

Michelle Doig joined Omega in 2016 and is a Partner and Head of Corporate Development. Her previous career included Third Rock Ventures, Abingworth and investment banking. She studied at the University of Western Ontario and Ivey Business School.

Bernard Davitian joined Omega as a Partner in 2020. He previously served as Senior Vice President and Managing Director of Sanofi Ventures and held corporate leadership roles at Fovea Pharmaceuticals, Neurotech, Transgene and Institut Merieux.

Otello Stampacchia founded Omega Funds in 2004 and is a Managing Director and investment-committee member. His earlier career included AlpInvest, Lombard Odier, Goldman Sachs and Index. He trained in pharmacogenetics and molecular biology at Pavia and Geneva.

Deirdre Cunnane joined Omega in 2019 as Chief Operating Officer and General Counsel. She previously led legal affairs at Catabasis Pharmaceuticals, Advanced Technology Ventures and Lightstone Ventures, and worked in venture investing at BancBoston. She holds Boston College law and finance degrees.

Eric Cooper joined Omega Funds as Chief Financial Officer in 2026 after 28 years at ABRY Partners, where his senior finance responsibilities included fund accounting, compliance and investor reporting. He holds a University of Massachusetts finance degree and an MIT MBA.

Daniela Leal Vargas is recorded in the official mercantile bulletin as Innvierte’s non-director deputy board secretary, appointed in May 2025. This is a statutory secretarial affiliation rather than a board director or portfolio investment attribution; further public career details and an authentic portrait were not established in the reviewed sources.

César-Mateo Espert Rodríguez is recorded by the official mercantile bulletin as Innvierte’s non-director board secretary, appointed in May 2025. The same filing expressly identifies him as non-member secretary of the internal control and communication body. A secretary affiliation does not imply a board director or investor role.

Ana Isabel Villoria Gajate served on the Innvierte Economía Sostenible board in 2025. The official mercantile bulletin records her appointment in March 2025 and her cessation in an entry registered on 28 July 2025, alongside María Ángeles Cano Díaz’s appointment. Registry-entry dates are distinguished from exact effective appointment or departure days, which are not established for her by the reviewed sources. She is represented as a historical statutory director rather than part of the current CNMV roster.

María Ángeles Cano Díaz is listed by the CNMV as an Innvierte Economía Sostenible director effective 17 July 2025. The official mercantile bulletin records the appointment on 28 July 2025 after Ana Isabel Villoria Gajate ceased as a director. The effective appointment date and registry entry date are distinct; additional career history and authentic portrait remain unconfirmed.

Ana Isabel Vega Escudero is listed by Spain’s securities regulator as an Innvierte Economía Sostenible board member appointed on 28 February 2025. The March 2025 official mercantile bulletin also records her appointment. This is a source-scoped statutory governance affiliation, with further professional biography and authentic portrait not published in the reviewed registry.

María Antonia Scheifler Alácano is a statutory director of Innvierte Economía Sostenible, the self-managed state investment company owned by CDTI. The CNMV official register records her appointment on 27 February 2024. The CDTI programme page separately uses the shorter published name Marian Scheifler Alácano; that spelling discrepancy is retained in the institution source audit rather than creating a second assumed person. Additional career details and portrait are not confirmed by the reviewed legal register.

Anatolio Alonso Pardo is publicly identified by Spain’s European Funds administration as Deputy Director General for management of the European Regional Development Fund. He previously served as an Innvierte board member. The official mercantile bulletin records his cessation in an entry registered on 21 March 2025, despite the older CDTI web directory retaining his name. That registry-entry day is not asserted as his exact effective departure day.

Pedro Mier Albert is publicly listed by CDTI in its external strategic advisory council. This consultative body provides expert guidance on innovation and monitors the 2024–2027 strategic plan; the affiliation is not a permanent agency staff position.

Carmen Vela Olmo is publicly listed by CDTI in its external strategic advisory council. This consultative body provides expert guidance on innovation and monitors the 2024–2027 strategic plan; the affiliation is not a permanent agency staff position.

Patricia Tamés Ortega is publicly listed by CDTI in its external strategic advisory council. This consultative body provides expert guidance on innovation and monitors the 2024–2027 strategic plan; the affiliation is not a permanent agency staff position.

Álvaro Simón de Blas is publicly listed by CDTI in its external strategic advisory council. This consultative body provides expert guidance on innovation and monitors the 2024–2027 strategic plan; the affiliation is not a permanent agency staff position.

Elisabet Roselló Román is publicly listed by CDTI in its external strategic advisory council. This consultative body provides expert guidance on innovation and monitors the 2024–2027 strategic plan; the affiliation is not a permanent agency staff position.

César Ramos Villena is publicly listed by CDTI in its external strategic advisory council. This consultative body provides expert guidance on innovation and monitors the 2024–2027 strategic plan; the affiliation is not a permanent agency staff position.

Laura Olcina Puerto is publicly listed by CDTI in its external strategic advisory council. This consultative body provides expert guidance on innovation and monitors the 2024–2027 strategic plan; the affiliation is not a permanent agency staff position.

Cecilia Medina Marín is publicly listed by CDTI in its external strategic advisory council. This consultative body provides expert guidance on innovation and monitors the 2024–2027 strategic plan; the affiliation is not a permanent agency staff position.

Francisco Marín Pérez is publicly listed by CDTI in its external strategic advisory council. This consultative body provides expert guidance on innovation and monitors the 2024–2027 strategic plan; the affiliation is not a permanent agency staff position.

José Manuel Leceta García is publicly listed by CDTI in its external strategic advisory council. This consultative body provides expert guidance on innovation and monitors the 2024–2027 strategic plan; the affiliation is not a permanent agency staff position.

Raquel Jorge Ricart is publicly listed by CDTI in its external strategic advisory council. This consultative body provides expert guidance on innovation and monitors the 2024–2027 strategic plan; the affiliation is not a permanent agency staff position.

Laura González-Estéfani is publicly listed by CDTI in its external strategic advisory council. This consultative body provides expert guidance on innovation and monitors the 2024–2027 strategic plan; the affiliation is not a permanent agency staff position.

Daniel González Bootello is publicly listed by CDTI in its external strategic advisory council. This consultative body provides expert guidance on innovation and monitors the 2024–2027 strategic plan; the affiliation is not a permanent agency staff position.

Joaquín Gómez Gómez is publicly identified by CDTI as Director of the Instituto de Fomento de la Región de Murcia (INFO) and is listed on its external strategic advisory council. He participates in public innovation-financing cooperation between INFO and CDTI. This is the Murcia institutional official, distinct from the existing Sherry Ventures investor with a similar shortened name.

Xavier Ferrás Hernández is publicly listed by CDTI in its external strategic advisory council. This consultative body provides expert guidance on innovation and monitors the 2024–2027 strategic plan; the affiliation is not a permanent agency staff position.

Soledad Díaz Campos is publicly listed by CDTI in its external strategic advisory council. This consultative body provides expert guidance on innovation and monitors the 2024–2027 strategic plan; the affiliation is not a permanent agency staff position.

Víctor Cruz Salgado is publicly listed by CDTI in its external strategic advisory council. This consultative body provides expert guidance on innovation and monitors the 2024–2027 strategic plan; the affiliation is not a permanent agency staff position.

Ignacio Cristóbal Sánchez is publicly listed by CDTI in its external strategic advisory council. This consultative body provides expert guidance on innovation and monitors the 2024–2027 strategic plan; the affiliation is not a permanent agency staff position.

Eduardo Cotillas Provencio is publicly listed by CDTI in its external strategic advisory council. This consultative body provides expert guidance on innovation and monitors the 2024–2027 strategic plan; the affiliation is not a permanent agency staff position.

Rocío Arroyo Arranz is publicly listed by CDTI in its external strategic advisory council. This consultative body provides expert guidance on innovation and monitors the 2024–2027 strategic plan; the affiliation is not a permanent agency staff position.

Cecilia Hernández Rodríguez is publicly listed by CDTI in its governance directory. The published professional remit is Consejo Rector member; Director of Industry Programmes, Agencia Espacial Española. This profile records that source-scoped public responsibility; additional career history is not inferred.

Roi Villar Vázquez is publicly listed by CDTI in its governance directory. The published professional remit is Consejo Rector member; Senior Public Research Organisations Technician, Instituto de Salud Carlos III. This profile records that source-scoped public responsibility; additional career history is not inferred.

María Isabel Pérez-Cerdá Herrero is publicly listed by CDTI in its governance directory. The published professional remit is Consejo Rector member; Head of Platforms and Robotics Unit, Ministry of Defence. This profile records that source-scoped public responsibility; additional career history is not inferred.

Nuria Valcárcel Sanz is publicly listed by CDTI in its governance directory. The published professional remit is Consejo Rector member; Head of Technical Cabinet, General Secretariat for Innovation. This profile records that source-scoped public responsibility; additional career history is not inferred.

Justo Jorge Pagán Guillén is publicly listed by CDTI in its governance directory. The published professional remit is Consejo Rector member; Deputy Director General for Industrial Project Promotion, Ministry of Industry and Tourism. This profile records that source-scoped public responsibility; additional career history is not inferred.

José Guimón de Ros is publicly listed by CDTI in its governance directory. The published professional remit is Consejo Rector member; Scientific Adviser to the Minister of Science, Innovation and Universities. This profile records that source-scoped public responsibility; additional career history is not inferred.

Tomás Fraile Santos is publicly listed by CDTI in its governance directory. The published professional remit is Consejo Rector member; Technical Cabinet Adviser, Science and Innovation Undersecretariat. This profile records that source-scoped public responsibility; additional career history is not inferred.

Francisco Javier Garzón Morales is publicly listed by CDTI in its governance directory. The published professional remit is Consejo Rector member; Deputy Director General for Communications, Ministry of Economy, Trade and Enterprise. This profile records that source-scoped public responsibility; additional career history is not inferred.

José Luis Calvo Labra is publicly listed by CDTI in its governance directory. The published professional remit is Consejo Rector member; Deputy Director General for Information and Communications Technologies, Ministry of Economy, Trade and Enterprise. This profile records that source-scoped public responsibility; additional career history is not inferred.

Lucía Díaz León is publicly listed by CDTI in its governance directory. The published professional remit is Consejo Rector member; Deputy Director General for Financial Administration and General Services, Ministry of Economy, Trade and Enterprise. This profile records that source-scoped public responsibility; additional career history is not inferred.

María Isabel Fernández Santos is publicly listed by CDTI in its governance directory. The published professional remit is Consejo Rector member; Adviser, Ministry of Science, Innovation and Universities Undersecretariat. This profile records that source-scoped public responsibility; additional career history is not inferred.

José María Ocón Alcoceba is publicly listed by CDTI in its governance directory. The published professional remit is Consejo Rector member; Head of European Funds Aid Management subdivision, Agencia Estatal de Investigación. This profile records that source-scoped public responsibility; additional career history is not inferred.

Antonio Alcolea Muñoz is publicly listed by CDTI in its governance directory. The published professional remit is Consejo Rector member; Deputy Director General for Programmes, Governance and Promotion, Directorate General for Data. This profile records that source-scoped public responsibility; additional career history is not inferred.

María Vega Gil Díaz is Economics and business graduate from Universidad del País Vasco, with financial-engineering and venture-capital training. Worked in audit at Argentaria and risk analysis at Extebandes before joining CDTI in1991. Led financial evaluation and financing/investment departments and is publicly listed as an ENISA board member.

Juan Antonio Tébar Chumillas is Aeronautical engineer and international MBA graduate from UPM with leadership and innovation programmes at IESE, MIT, Comillas and ESADE. Worked on the A 400 M at EADS/CASA before joining CDTI in2008, progressing through European framework-programme leadership. Represents Spain in Horizon Europe and EIT policy bodies and sits on the ENSA board.

Carlos de la Cruz Molina is Industrial engineer from Universidad Politécnica de Madrid with an international MBA and venture-capital training. Began in1987 at LCOE and worked as a project engineer at CLH before joining CDTI in1990. Held technology evaluation and departmental leadership posts; the current directory heading states Technology and Internationalisation, while its older biography retains the earlier Technical Evaluation title.

Miguel Valle García is Economics graduate with morethan 20 years designing, managing and evaluating public R&D and innovation policy. Joined CDTI in2006 and worked in innovation promotion, studies, communications and strategy. Previously led strategy and evaluation, coordinating programmes including Misiones, Cervera and innovation-transfer ecosystems.

María Pilar Carrato Mena is Business graduate of CUNEF with financial and public-management training. Began as a Banco de España financial analyst and worked thirteenyears in private financial institutions before joining Spain’s senior state audit/intervention corps. Served as secretary general of ICAC and audited European funds at IGAE, joining CDTI in November2018.

Javier Pérez Torrijos is Law graduate of Universidad Autónoma de Madrid with European Communities studies at ICADE, public-international-law research at UNED and corporate legal training at IE. Previously handled legal matters for the Innvierte capital-risk programme at CDTI, served as deputy legal adviser and board deputy secretary at SEPI, and spent over 20 years in CDTI legal services.

José Moisés Martín Carretero is Economist trained at Universidad Autónoma de Madrid, with postgraduate finance and computational-methods studies and executive training at MIT and INSEAD. Before directing CDTI he led consultancy Red 2 Red from 2014 and has more than 25 years of public/private experience. Previously managed multilateral cooperation at AECID and taught economics and technological entrepreneurship at Universidad Camilo José Cela from2016–2024.

Teresa Riesgo Alcaide is Spain’s Secretary General for Innovation and a professor of electronic technology at Universidad Politécnica de Madrid. She has directed its Industrial Electronics Centre and led research and international relations at its industrial engineering school. Her research covers embedded systems, reconfigurable hardware and Internet-of-Things electronics; she holds an industrial engineering doctorate from UPM.

Robert Picarel is the founder of TNBT Capital and the president named in the French active-company registry. TNBT's own biography describes software-engineering training followed by marketing and consulting work, then the co-founding of Velvet Consulting in2004 with a focus on customer strategy, data and digital transformation. WPP's September4,2020 acquisition announcement independently names him and Fabienne Magot as Velvet's founders. TNBT reports that he remained Velvet's non-executive chairman until2025 and developed the family-office activity in2021. His own advisory-board host describes earlier work at Capgemini and Nielsen and an engineering degree fromCYTech; these are source-attributed career details without invented employment or graduation days. Only his verified TNBT founder/president role is recorded here. The published adviser-card portrait is explicitly bound to his name and TNBT chairman biography.

Kate Chan is named as the Data Protection Officer in QuantumLight’s own privacy policy for Quantum Light Management Ltd. The policy identifies her as the contact for privacy questions and data-subject rights. It does not establish whether she is employed by the manager or provides the function externally, and no broader career identity is assumed.

Evgeny Obukhov describes his work as data science and machine-learning research at an AI-driven venture firm founded by Nik Storonsky, and lists QuantumLight in his published experience. His own profile shares the QuantumLight–Vento analysis of anonymized founder-program applicant assessments; current tenure is not independently established.

Stephanie Manz-Varga announced joining QuantumLight in London on October 30, 2025 to work with Series B and Series C founders. Her announcement names the investment and technical team she was joining; formal job title and current tenure are not established by this dated post.

Ruggero Pesciatini is named in QuantumLight business-builder Ezio Mantegazza’s May21,2025 account of developing the firm and its investment platform. The source associates this person with building or supporting the business; formal job title and current tenure are not established by that historical account.

Tommaso Pace is named in QuantumLight business-builder Ezio Mantegazza’s May21,2025 account of developing the firm and its investment platform. The source associates this person with building or supporting the business; formal job title and current tenure are not established by that historical account.

Ruslan Sungatullin is named in QuantumLight business-builder Ezio Mantegazza’s May21,2025 account of developing the firm and its investment platform. The source associates this person with building the AI system; formal job title and current tenure are not established by that historical account.

Alexey Lazarev is named in QuantumLight business-builder Ezio Mantegazza’s May21,2025 account of developing the firm and its investment platform. The source associates this person with building the AI system; formal job title and current tenure are not established by that historical account.

Saveliy Tatarskikh is named in QuantumLight business-builder Ezio Mantegazza’s May21,2025 account of developing the firm and its investment platform. The source associates this person with building the AI system; formal job title and current tenure are not established by that historical account.

Aleksandr Proskurin is named in QuantumLight business-builder Ezio Mantegazza’s May21,2025 account of developing the firm and its investment platform. The source associates this person with building the AI system; formal job title and current tenure are not established by that historical account.

Artem Gogin is named in QuantumLight business-builder Ezio Mantegazza’s May21,2025 account of developing the firm and its investment platform. The source associates this person with building the AI system; formal job title and current tenure are not established by that historical account.

Nikita Ovsov is named in QuantumLight business-builder Ezio Mantegazza’s May21,2025 account of developing the firm and its investment platform. The source associates this person with building the AI system; formal job title and current tenure are not established by that historical account.

Elizabeth Morozova is named in QuantumLight business-builder Ezio Mantegazza’s May21,2025 account of developing the firm and its investment platform. The source associates this person with building or supporting the business; formal job title and current tenure are not established by that historical account.

Anton Trubakov is named in QuantumLight business-builder Ezio Mantegazza’s May21,2025 account of developing the firm and its investment platform. The source associates this person with building or supporting the business; formal job title and current tenure are not established by that historical account.

Ezio Mantegazza is named in QuantumLight business-builder Ezio Mantegazza’s May21,2025 account of developing the firm and its investment platform. The source associates this person with building or supporting the business; formal job title and current tenure are not established by that historical account.

Andrew Stepanov is published in QuantumLight’s current own team directory as Chief of AI.

Maryna Omelchenko is published in QuantumLight’s current own team directory as Partner - Fundraising.

Chandler Kallas is published in QuantumLight’s current own team directory as Partner.

Christian Repole is published in QuantumLight’s current own team directory as Partner.

Louis Fontaine is published in QuantumLight’s current own team directory as Partner.

Dora Zikouli is published in QuantumLight’s current own team directory as Partner.

Tommaso Conca is published in QuantumLight’s current own team directory as Partner.

Ilya Kondrashov is published in QuantumLight’s current own team directory as CEO.

Nik Storonsky is published in QuantumLight’s current own team directory as Founder. The same website identifies him as Revolut’s CEO and co-founder and describes the firm’s use of his operating playbooks.

Anna Legg was Global Kinetics’ Chief Financial Officer before the company’s December2020 announcement of Thomas Ulmer’s appointment. The issuer expressly said she was stepping down to pursue other opportunities. Her historical financial leadership is recorded without assuming an exact final employment day or a current role within PKG Health/Empatica.

John Schellhorn was appointed President and CEO of Global Kinetics Corporation in October2017. The issuer’s own syndicated release describes more than thirty years in medical devices and prior leadership at Barrx Medical and Softscope Medical Technologies, which was acquired by Fujifilm. Subsequent PKG leadership sources identify different CEOs, so this is a historical role rather than a current post-acquisition appointment.

Andrew Maxwell was Global Kinetics Corporation’s Managing Director at its completed June2015 private placement. The issuer’s release describes his responsibility for international commercial expansion, manufacturing and introduction of the next PKG generation following regulatory clearances. This dated leadership is historical; later employment and current board tenure are not asserted.

Robert Griffiths is the technology co-founder identified alongside Malcolm Horne on PKG Health’s own company history. Their Parkinson’s KinetiGraph work underlies wearable movement measurement and reporting for clinical care and research. The archived issuer source establishes founder attribution, not current employment or a statutory director appointment; unrelated people named Robert Griffiths are not merged.

Malcolm Horne is a neurologist and neuroscience researcher identified by Global Kinetics/PKG Health as a technology founder alongside Robert Griffiths. His University of Melbourne programme studies objective measurement of Parkinson’s and other movement disorders; that research produced the commercial Parkinson’s KinetiGraph. Founder attribution does not establish current executive employment after the Empatica acquisition.

David Atkins joined Global Kinetics’ board in May2023 as a BioScience Managers representative. The manager’s October2022 biography describes his prior Congenica leadership and senior roles at Johnson & Johnson, Danaher and Medicover. His qualifications include a Columbia MBA, molecular-virology PhD at John Innes, UNSW pharmacology study and University of East Anglia biological-sciences degree. Later PKG board tenure following acquisition is not established.

Mandy Hagley is the Finance Director named in PKG Health’s February2025 leadership announcement and July2025 directory. The directory directly links her card to Samantha Hagley’s professional profile, while the issuer’s own social announcement uses Samantha; these primary links qualify the Mandy/Samantha name variant. Her role supports financial leadership during the company’s expansion. Continued employment after the2025 acquisition is not assumed.

Dan Bennett is PKG Health’s partnerships executive, promoted to Chief Business Officer in February2025. The issuer assigns him responsibility for life-science company and algorithm-licensing partnerships. Empatica’s own December2025 conference announcement still identifies him as PKG Health CBO after the acquisition. The individually published PKG portrait and linked danbennett1 profile distinguish this executive from the protected OurCrowd/Salus investor also named Dan Bennett.

Muhammad Umer is the engineering leader identified by PKG Health’s own November2023 directory as Vice President Technology and its July2025 directory as Chief Technology Officer. His company-linked professional profile identifies the Gen3 PKG Watch development project in2021–2023, involving hardware and firmware upgrades and Melbourne design partner Outerspace. His exact post-acquisition employment status is unpublished in the recovered issuer sources.

Neil Stevens led PKG Health’s Europe/Middle East business before promotion to Chief Commercial Officer EMEA in February2025. The company assigns this role responsibility for its clinical-care operations in Europe, the Middle East and Australia, after expanding patient access in those regions. His July2025 listing is the last recovered pre-acquisition directory; continued2026 tenure is not inferred.

Karen Krygier was PKG Health’s published Chief Strategy Officer in its November2023 directory. A company-sponsored TARGET-PD statistical analysis plan identifies her as Director of Clinical Research in September2020. Her work concerns clinical evidence for objective Parkinson’s monitoring. She is absent from the recovered July2025 operating directory, so continued employment or a precise departure date is not asserted.

Thomas Ulmer was appointed Global Kinetics CFO effective April2021 after serving as CFO of Immatics N.V. He initially advised the company from December2020. PKG Health appointed him interim CEO in February2025, following his Chief Operating and Financial Officer role; its July2025 directory labels him CEO. These are pre-acquisition appointments; no continuing independent CEO tenure after Empatica’s2025 acquisition is inferred.

Leighton Read is an American physician, entrepreneur and venture investor who joined Brandon Capital in2015. He previously led Interhealth Partners and Alloy Ventures, founded Affymax’s pharmaceutical division and was founding investor, chair and CEO of Aviron and Avidia. His primary biography identifies Rice University and University of Texas medical education plus Duke/Brigham internal-medicine training. He transitioned from Global Kinetics executive chair to non-executive chair in May2023 and is named PKG Health chairman in the completed2025 acquisition announcement.

Khalid Al-Saleh is Riyadh Valley Company’s chief executive officer as explicitly identified in itsSeptember25,2025 Abies Ventures FundII investment announcement and earlierMarch2021 Global Kinetics release. His own King Saud University faculty CV identifies Khalid Saad Al-Saleh as an associate professor of industrial engineering, with a1993 KingSaud bachelor’s degree and a2004 Birmingham PhD. His teaching and research cover human factors, ergonomics, cognitive and physical workload, patient safety, technology transfer and entrepreneurship. This is the university industrial engineer, distinct from the same-name clinical oncology/hematology physician. RVC’s full current executive directory and the continuation of his tenure after the latest dated confirmation are not independently published.

Sara A. Alhusaini is a named member of Riyadh Valley Company’s publicly listed governance structure, serving in Nomination and Remuneration Committee. RVC is King Saud University’s commercial knowledge-economy and strategic-project investment arm. The company’s current primary roster establishes this institutional affiliation; it does not publish a detailed individual career biography, education or appointment date. Committee and board affiliations are organizational governance roles, not evidence of a personal investment ticket.

Faisal S. Alyemni is a named member of Riyadh Valley Company’s publicly listed governance structure, serving in Nomination and Remuneration Committee. RVC is King Saud University’s commercial knowledge-economy and strategic-project investment arm. The company’s current primary roster establishes this institutional affiliation; it does not publish a detailed individual career biography, education or appointment date. Committee and board affiliations are organizational governance roles, not evidence of a personal investment ticket.

Abdulmajeed M. Al-Fadhli is a named member of Riyadh Valley Company’s publicly listed governance structure, serving in Audit Committee. RVC is King Saud University’s commercial knowledge-economy and strategic-project investment arm. The company’s current primary roster establishes this institutional affiliation; it does not publish a detailed individual career biography, education or appointment date. Committee and board affiliations are organizational governance roles, not evidence of a personal investment ticket.

Abeer Y. Alsalloom is the published chair of RVC’s audit committee. Her King Saud University faculty profile identifies Abeer Yousef Alsalloom as an accounting academic and head of the accounting department in the College of Business Administration. Her work examines gender, institutional constraints and professional practice in Saudi audit firms; the university profile lists internal auditing, corporate governance and management-accounting teaching. Exact RVC committee tenure dates are unpublished.

Abdulaziz A. Albassam is a named member of Riyadh Valley Company’s publicly listed governance structure, serving in Investment and Finance Committee. RVC is King Saud University’s commercial knowledge-economy and strategic-project investment arm. The company’s current primary roster establishes this institutional affiliation; it does not publish a detailed individual career biography, education or appointment date. Committee and board affiliations are organizational governance roles, not evidence of a personal investment ticket.

Abdulaziz M. Algabbani is a named member of Riyadh Valley Company’s publicly listed governance structure, serving in Investment and Finance Committee. RVC is King Saud University’s commercial knowledge-economy and strategic-project investment arm. The company’s current primary roster establishes this institutional affiliation; it does not publish a detailed individual career biography, education or appointment date. Committee and board affiliations are organizational governance roles, not evidence of a personal investment ticket.

Andrea Longhi is a currently published RVC board member. King Saud University’s own2025 transformation newsletters identify him as chief transformation officer overseeing the university’s transformation programme and its governance, people and institutional development. RVC’s website reuses the same portrait file for three differently named people, so no identity-unverified RVC image is attached. Exact RVC appointment date and further education history are unpublished.

Faiz A. Alahmary is a named member of Riyadh Valley Company’s publicly listed governance structure, serving in Board Member and Audit Committee. RVC is King Saud University’s commercial knowledge-economy and strategic-project investment arm. The company’s current primary roster establishes this institutional affiliation; it does not publish a detailed individual career biography, education or appointment date. Committee and board affiliations are organizational governance roles, not evidence of a personal investment ticket.

Abdullah A. Alsulaimi is a named member of Riyadh Valley Company’s publicly listed governance structure, serving in Board Member. RVC is King Saud University’s commercial knowledge-economy and strategic-project investment arm. The company’s current primary roster establishes this institutional affiliation; it does not publish a detailed individual career biography, education or appointment date. Committee and board affiliations are organizational governance roles, not evidence of a personal investment ticket.

Ibrahim H. Al-Rashid is a named member of Riyadh Valley Company’s publicly listed governance structure, serving in Board Member and Nomination and Remuneration Committee. RVC is King Saud University’s commercial knowledge-economy and strategic-project investment arm. The company’s current primary roster establishes this institutional affiliation; it does not publish a detailed individual career biography, education or appointment date. Committee and board affiliations are organizational governance roles, not evidence of a personal investment ticket.

Nasser A. Al Kadi is a named member of Riyadh Valley Company’s publicly listed governance structure, serving in Board Member and Investment and Finance Committee. RVC is King Saud University’s commercial knowledge-economy and strategic-project investment arm. The company’s current primary roster establishes this institutional affiliation; it does not publish a detailed individual career biography, education or appointment date. Committee and board affiliations are organizational governance roles, not evidence of a personal investment ticket.

Yazeed A. Al-Humied is a currently published RVC board member. PIF’s own leadership biography identifies him as deputy governor and head of MENA investments, a role assumed in2021 after serving as chief of staff from his2015 arrival. He previously led the Capital Market Authority’s mergers-and-acquisitions team and worked at PwC. He holds an accounting degree from King Saud University. These institutional investment responsibilities do not establish a personal cash check.

Katharine Giles is venture partner - perth at Brandon Capital. She joined in2012 after investing at Stone Ridge Ventures. Her medical-device and startup work includes OncoRes leadership, digital breast-health tools and co-founding the Spark Co-Lab innovation-education initiative. These career statements come from the firm’s own biography; other company affiliations do not establish personal cash investments, and exact appointment days are not inferred.

David Fisher is partner emeritus at Brandon Capital. He helped found Brandon Capital after establishing Brandon Capital Management and its life-sciences pooled-development-fund activities. His earlier career includes Peptech leadership and Pharmacia work. His directory title Partner Emeritus expressly scopes his current affiliation. These career statements come from the firm’s own biography; other company affiliations do not establish personal cash investments, and exact appointment days are not inferred.

Ibrahim S. Almojel is RVC’s currently published board chairman. Stanford’s own faculty biography identifies Ibrahim Almojel as a lecturer in management and founding partner of Khwarizmi Holding, with prior CEO roles at Saudi Industrial Development Fund and Saudi Aramco’s Wisayah investment arm. He studied electrical engineering and mathematics at Vanderbilt and earned electrical-engineering and management-science graduate degrees, including a PhD, at Stanford. RVC’s chair appointment date is unpublished.

Roberto Solari is venture partner - united kingdom at Brandon Capital. His Brandon affiliation dates to2007. He co-founded Myricx Bio and previously led respiratory biology at GSK and the Medical Research Council’s commercialisation organisation, helping establish biotechnology spinouts. These career statements come from the firm’s own biography; other company affiliations do not establish personal cash investments, and exact appointment days are not inferred.

Robert Daniels is venture partner - sydney at Brandon Capital. He joined in2021 following leadership of Elastagen from research spinout through clinical development and acquisition integration. His educational background spans Leeds science, UCL doctoral research and Swinburne entrepreneurship/innovation. These career statements come from the firm’s own biography; other company affiliations do not establish personal cash investments, and exact appointment days are not inferred.

Robin Carr is advisor, united kingdom at Brandon Capital. He joined in2021 with drug-discovery leadership experience at Glaxo Wellcome, GSK and Astex. His earlier responsibilities encompassed small-molecule and biologics discovery platforms and partnered/internal therapeutic programmes. These career statements come from the firm’s own biography; other company affiliations do not establish personal cash investments, and exact appointment days are not inferred.

Rana Ali is portfolio manager - new zealand at Brandon Capital. She joined in2021 following global animal-health innovation leadership at Argenta. Her experience covers pharmaceutical R&D/manufacturing, engineering projects, commercialisation, licensing and New Zealand/US operations. These career statements come from the firm’s own biography; other company affiliations do not establish personal cash investments, and exact appointment days are not inferred.

Ian Holmes is preclinical project advisor - melbourne at Brandon Capital. He joined in2017 after medicinal-chemistry consulting, Cancer Therapeutics CRC leadership and research roles at GSK and Zeneca. He co-founded MycRx and Foray and advises therapeutic-development companies, bringing preclinical drug-discovery expertise. These career statements come from the firm’s own biography; other company affiliations do not establish personal cash investments, and exact appointment days are not inferred.

Madeleine Pantaleo is office assistant at Brandon Capital. She joined in2025 with a healthcare background spanning enrolled nursing, patient-facing administration and specialist/allied-health settings. Her earlier Bupa work involved corporate relationships, payroll and finance administration. These career statements come from the firm’s own biography; other company affiliations do not establish personal cash investments, and exact appointment days are not inferred.

Fiona Mascarenhas is financial accountant at Brandon Capital. She joined in2023 after finance roles at IKEA Dubai and Dixon Advisory Melbourne. Her professional membership is with Chartered Accountants Australia and New Zealand; she studied commerce at Monash and financial technologies at Swinburne. These career statements come from the firm’s own biography; other company affiliations do not establish personal cash investments, and exact appointment days are not inferred.

Nikki Williams-Aslimoski is office manager & team assistant at Brandon Capital. She joined in2021 following international freight and logistics work at Expeditors and Clemenger. Her experience spans customs, transport coordination and distribution, before her office-management and team-support role. These career statements come from the firm’s own biography; other company affiliations do not establish personal cash investments, and exact appointment days are not inferred.

Sean Creedon is senior fund accountant at Brandon Capital. He joined in2021 after fund-accounting experience at Citco, IFM and BNP Paribas. His background includes fund launches and accounting-system projects, with mathematics/economics and business-information-systems studies at University College Cork. These career statements come from the firm’s own biography; other company affiliations do not establish personal cash investments, and exact appointment days are not inferred.

Deepali Dhawan is manager, corporate finance at Brandon Capital. She joined in2016 after fund-accounting work at Link Market Services and Primary Superannuation Services. Her finance responsibilities include reporting, audits, governance, systems and financial controls; earlier work involved telecommunications revenue analysis. These career statements come from the firm’s own biography; other company affiliations do not establish personal cash investments, and exact appointment days are not inferred.

Ruth Heenan is head of brand, marketing & communications at Brandon Capital. She joined in2025 with marketing and communications experience across healthcare, finance, nonprofit, government and commercial organisations. Her work emphasises public engagement, stakeholder relationships and strategic communications. These career statements come from the firm’s own biography; other company affiliations do not establish personal cash investments, and exact appointment days are not inferred.

Robert Sicilia is head of investor relations at Brandon Capital. He joined in2024 after investment strategy, asset allocation and private-market work for Australian superannuation funds and JANA. His background includes manager diligence, co-investments, real assets and stakeholder relations. These career statements come from the firm’s own biography; other company affiliations do not establish personal cash investments, and exact appointment days are not inferred.

Dianne Climent-Ruiz is senior executive assistant & head of administration at Brandon Capital. She joined in2017 and supports the founding partners, investment team and portfolio executives. Her responsibilities include administration, stakeholder coordination and support for Brandon BioCatalyst’s governing directors; this is operational support rather than her own statutory board appointment. These career statements come from the firm’s own biography; other company affiliations do not establish personal cash investments, and exact appointment days are not inferred.

Kate Groombridge is general counsel at Brandon Capital. She joined in2015 with litigation, commercial advisory and government-law experience. Her legal career includes Buddle Findlay and the UK Treasury Solicitor, with admissions in Victoria, England/Wales and New Zealand. These career statements come from the firm’s own biography; other company affiliations do not establish personal cash investments, and exact appointment days are not inferred.

Dom Marot is chief financial officer at Brandon Capital. He joined in2024 with experience in UK and Australian investment finance. Previous responsibilities at Coller Capital and Rest Industry Super encompassed fund accounting, performance, investment operations and asset-owner finance. These career statements come from the firm’s own biography; other company affiliations do not establish personal cash investments, and exact appointment days are not inferred.

Marium Rana is analyst, cureator at Brandon Capital. She entered CUREator in2025 after scientific work at Sygnature Discovery and commercial-strategy analysis at Kesmalea Therapeutics. Her Birmingham biochemistry doctorate and honours science degree concern anticancer discovery and translational research. These career statements come from the firm’s own biography; other company affiliations do not establish personal cash investments, and exact appointment days are not inferred.

Aaron DeBono is program manager, cureator at Brandon Capital. He joined in2022 after biomedical business development at Murdoch Children’s Research Institute and medicinal-chemistry research at Monash. His translational work spans drug, device and digital-health commercialisation, including programmes involving GSK and defence research. These career statements come from the firm’s own biography; other company affiliations do not establish personal cash investments, and exact appointment days are not inferred.

Patricia Rueda is program manager, cureator at Brandon Capital. She joined in2022 after corporate development at Audax/oNKo-innate and management of a Monash-Servier drug-discovery collaboration. Her experience spans translational project work, target assessment and lead optimisation. Current directory Program Manager supersedes older Analyst wording in her biography. These career statements come from the firm’s own biography; other company affiliations do not establish personal cash investments, and exact appointment days are not inferred.

Christina Kulis is analyst, cureator at Brandon Capital. She joined in2021 and supports CUREator’s early biomedical commercialisation. Her earlier work includes Brandon investment analysis and Queensland drug-discovery programmes; a REDI industry fellowship supported her transition into venture work. These career statements come from the firm’s own biography; other company affiliations do not establish personal cash investments, and exact appointment days are not inferred.

Amanda Vrselja is program head, cureator at Brandon Capital. She joined the founding CUREator team in2021 and leads its biomedical translation/incubation activities. Previously she was a clinical scientist at QUE Oncology, coordinating research strategy and a multinational PhaseII programme. These career statements come from the firm’s own biography; other company affiliations do not establish personal cash investments, and exact appointment days are not inferred.

Melissa Byrne is senior investment associate at Brandon Capital. She joined in2018 after cardiovascular physiology and translational research at Baker Heart Institute. Her work includes preclinical device/therapeutic studies, early human trials and inventions supporting movement of medical research into clinical care. These career statements come from the firm’s own biography; other company affiliations do not establish personal cash investments, and exact appointment days are not inferred.

Elliott Dunn is associate at Brandon Capital. He joined in2020 after research-project work at Blis Technologies and commercialisation analysis at Otago Innovation. His pharmacology background and2018 doctorate led to research-investment committee work and bioengineered burn-care projects. These career statements come from the firm’s own biography; other company affiliations do not establish personal cash investments, and exact appointment days are not inferred.

Prashanth Rajan is associate at Brandon Capital. He joined in2021 and works from Sydney on NSW investment activity. His previous UniSA Ventures role covered commercialisation, licensing and intellectual-property portfolios, with operating experience at AbRegen. These career statements come from the firm’s own biography; other company affiliations do not establish personal cash investments, and exact appointment days are not inferred.

Helga Mikkelsen is investment manager at Brandon Capital. She joined in2018 following work with Respirion’s founding team and respiratory/anti-infective technologies. Her training includes Danish chemical engineering/biotechnology, Cambridge microbiology and Imperial postdoctoral bacterial-genetics research. These career statements come from the firm’s own biography; other company affiliations do not establish personal cash investments, and exact appointment days are not inferred.

Alex Delbridge is principal at Brandon Capital. He returned to Melbourne in2025 after Boston-based investing at Omega Funds, multiple-sclerosis research at Biogen and drug-pricing/access consulting at Putnam. His biography describes prior board-observer work across preclinical and clinical therapeutic programmes. These career statements come from the firm’s own biography; other company affiliations do not establish personal cash investments, and exact appointment days are not inferred.

Michael Bettess is senior investment manager at Brandon Capital. His2016 Brandon appointment followed life-sciences business development at Monash and investment work at TTCF. He has worked on academic research commercialisation, pharmaceutical collaborations and biotechnology transactions, including Nexvet. These career statements come from the firm’s own biography; other company affiliations do not establish personal cash investments, and exact appointment days are not inferred.

Duncan Mackintosh is senior investment manager at Brandon Capital. He joined in2016 to build New Zealand activities after technology-transfer leadership at Waikato’s commercialisation company. His career includes KiwiNet research-commercialisation collaboration and earlier veterinary practice, including UK foot-and-mouth-response responsibilities. These career statements come from the firm’s own biography; other company affiliations do not establish personal cash investments, and exact appointment days are not inferred.

Trent Munro is venture partner at Brandon Capital. He joined in2026 after biotechnology research leadership at Queensland, executive work at Microba and Amgen. The public directory says Venture Partner while his individual biography says Partner; both published descriptions are retained without silently resolving the discrepancy. These career statements come from the firm’s own biography; other company affiliations do not establish personal cash investments, and exact appointment days are not inferred.

Bob Soh is partner at Brandon Capital. His2016 move to Brandon followed medical and operational leadership at Nucleus Network, where he worked on early clinical studies and trial capabilities. He also helped establish Cardiora and guided its heart-failure programme through clinical development before licensing. These career statements come from the firm’s own biography; other company affiliations do not establish personal cash investments, and exact appointment days are not inferred.

Chris Smith is partner at Brandon Capital. He entered Brandon in2012 after CSL business development and Cambridge postdoctoral research. His published portfolio-director affiliations concern Australian therapeutic businesses. He is distinct from the Chris Smith professionals at Playfair Capital, Curie Bio and Fractile. These career statements come from the firm’s own biography; other company affiliations do not establish personal cash investments, and exact appointment days are not inferred.

Melissa McBurnie is partner & head of impact at Brandon Capital. Her prior work combines seed-stage investing at Terra Rossa, business development at Bio Innovation SA and postdoctoral research at Prince Henry’s Institute. Adelaide science/immunology training and a South Australia finance-focused MBA underpin her research-commercialisation and impact work. These career statements come from the firm’s own biography; other company affiliations do not establish personal cash investments, and exact appointment days are not inferred.

Stephen Thompson is founding partner & managing director at Brandon Capital. His earlier career spans Apax Partners in London, product development at Cantab Pharmaceuticals and immunology research in London and California. His firm biography distinguishes current portfolio-director work from completed Elastagen and Longas affiliations. These career statements come from the firm’s own biography; other company affiliations do not establish personal cash investments, and exact appointment days are not inferred.

Chris Nave is founding partner & managing director at Brandon Capital. He also leads Brandon BioCatalyst as CEO. Earlier roles included commercialisation leadership at Baker IDI, biotechnology management at Melbourne Ventures, Uniseed investing and pharmaceutical business development at Leiras. His research training at Melbourne encompasses an honours science degree and an endocrinology/physiology doctorate. These career statements come from the firm’s own biography; other company affiliations do not establish personal cash investments, and exact appointment days are not inferred.

Chuck Carignan is named on Anaconda Biomed’s current public board of directors. The issuer identifies the affiliation as Board Chairman. This confirms the board relationship without establishing a personal investment.

Christophe Cognard is named on Anaconda Biomed’s current public scientific advisory board. The issuer describes the clinician’s external clinical affiliation as Chairman of the department of Diagnostic and Therapeutic Neuroradiology, University Hospitals Purpan and Rangueil Toulouse, France Since Dec. 2002. This is an advisory relationship rather than company employment.

Tommy Andersson is named on Anaconda Biomed’s current public scientific advisory board. The issuer describes the clinician’s external clinical affiliation as Director for Education in Neuroendovascular Treatment, Karolinska University Hospital Shared director for the Section of Neurointervention and Angiography at KERIC. This is an advisory relationship rather than company employment.

Tina oversees global clinical trial execution, including CRO management. She earned a Bachelor’s Degree in Nursing from St. John Fisher University and a Master’s Degree in Public and Health Care Administration from SUNY (Brockport). She is currently working toward a PhD in Clinical Research from the University of Jamestown. Her career started in patient care, then she transitioned to field sales and market development before moving into corporate roles including field clinical engineering, clinical trial management, and clinical affairs at Boston Scientific, Recor, and Elixir Medical prior to joining Anaconda.

Monica is an accomplished leader with 25 years in the pharmaceutical and medical device spaces. For Anaconda she manages compliance with global regulatory and quality standards. She holds a BS in Chemistry & Biochemistry from UC, San Diego and a Masters in Biotechnology from San Jose State University. She is experienced in developing, clearing, and bringing novel technologies to market, including Stryker Endoscopy’s first wireless surgical monitor, Abbott’s AbsorbTM Stent, and Eargo’s first self-fitting OTC hearing aid.

With a degree in Chemical Sciences from Institut Químic de Sarrià, Barcelona and a PhD in Organic Chemistry, Barcelona, Dr. Arad has 15 years of experience in the biomedical field. After a period developing pharmaceutical compounds and photosensitizers for Cancer Photodynamic Therapy, he developed multiple materials for the medical devices industry: biopolymers and their formulations for controlled drug release applications, lubricious coatings and radiopaque materials for endovascular catheters, chemical enhancement of biomaterials for aortic percutaneous valves and advanced adhesives for medical applications.

Jordi has more than 30 years of experience, primarily as Industrial Director in Medical Device business. He has led Production, Maintenance, Quality Control, Supply Chain, Engineering and R&D in multinational and big family companies. He has expertise in process automation and process outsourcing in India, China, and Tunisia and has successfully implemented several Lean Manufacturing, 5S, TPM, and continuous improvement (Kaizen) processes. He has a telecommunications engineer degree from La Salle (Ramon Llull University), a Master’s degree in Total Quality Management from Polytechnical Catalonia University, and an Executive MBA degree from La Salle (Ramon Llull University) and St. Mary’s College (San Francisco, California).

Maria Jose began her career at Anaconda as the Administrative Officer, and her role has expanded over time to encompass budgeting, forecasting, and financial reporting. She earned her bachelor’s degree in Finance from Tecnologico de Monterrey, followed by a Master’s from ESNECA Business School with a focus on payroll, social insurance, settlements and contracts.

Inaki’s background includes a chemistry degree, a Master’s Degree in Organic Chemistry and Biochemistry, and a PhD in Drug Discovery (Organic Chemistry) at Institut Químic de Sarrià (Barcelona). He has successfully worked in drug discovery, biopolymers, and medical devices development both in research and management roles. His main fields of working include cancer, immunological and neurodegenerative disorders, and cardiovascular diseases. He has been involved from early stages of product conception to late regulatory and commercialization. His recent achievements have been in the field of cardiovascular medical devices, mainly drug eluting stents.

Hendrik has a master’s degree in Electronic Engineering and PhD in Biomedical Engineering from the University of Ghent, Belgium. He has over 25 years of experience in the development of innovative medical device technologies in early start-ups and in large size international companies. He has experience in the field of cardiac, vascular and neurological therapies, always with the aim of creating new standards of care. Prior to joining Anaconda Biomed, he was the co-founder and Vice-President of Clinical & Regulatory Affairs at ONWARD Medical in Lausanne, Switzerland, and previously was Vice-President of Clinical & Regulatory Affairs at Endosense, which was acquired by St Jude Medical (now Abbott.

Trent is a seasoned MedTech executive with over 25 years of leadership experience spanning early-stage clinical development to global commercial execution in venture-backed, market-disruptive medical technologies. He brings a strong combination of strategic vision, operational execution, and proven success in fundraising, market expansion, clinical strategy, and medical device innovation to his role at Anaconda. Previously he was CEO of Mercator MedSystems, and Global Vice President of Commercial Operations at IDEV Technologies (acquired by Abbott for $310M). He also held executive roles at ROX Medical, Omnisonics, and RITA Medical. Trent holds a Bachelor of Science in Business from Colorado State University and an MBA from the Paul Merage School of Business at the University of California, Irvine.

Robert Starr, also called Bob Starr in ZAP Surgical’s published biography, leads human resources. He has more than twenty-five years of HR and business experience across medical imaging, radiotherapy, sleep medicine and dental technology. Previous roles include vice president of human resources and administration at MicroDental and ProSomnus, and vice-president responsibilities at ADAC. He earned a social-sciences bachelor’s degree with a human-resources minor from California Polytechnic State University, San Luis Obispo. Both Robert and Bob identify this same published executive.

Robert Wiggers leads hardware engineering at ZAP Surgical. His biography describes more than thirty years in hardware and automation, including about seventeen years in medical technology. His background includes semiconductor wafer-handling robotics and engineering at Verb Surgical, Varian and RefleXion. He holds bachelor’s and master’s degrees in mechanical engineering and controls; the published source does not identify the institutions. His role concerns the company’s robotic radiosurgery hardware, not an inferred outside board appointment.

Alex Maslowski, PhD, leads software at ZAP Surgical. His biography describes over twenty years of medical and scientific software development, including computational physics, distributed computing and radiation models. He earned nuclear-engineering bachelor’s and doctoral degrees at Texas A&M. He worked on Transpire’s Acuros radiation-dosimetry software before Varian’s 2014 acquisition and subsequently led algorithm, machine-learning and cloud development related to Eclipse. His expertise supports the company’s treatment-planning and software platform.

Yair Bauer serves as president of ZAP Surgical Japan and vice president for Asia-Pacific. His published biography places him in Tokyo and describes over twenty-two years in neurosurgical technology, clinical development and commercial operations across the region. Before ZAP he held country-manager and Asia-Pacific leadership responsibilities at INSIGHTEC. These are qualified regional roles within the company’s public group leadership roster; no separate subsidiary legal identity or investment allocation is inferred.

Chris Pegano leads sales in the Americas at ZAP Surgical. His company biography describes more than twenty years of commercial experience in medical devices, neuroscience and brain oncology. His recent career includes MRI-guided laser interstitial thermal therapy, responsive neurostimulation and neuroendoscopy technologies. He previously served as a United States Army infantry officer and holds a bachelor’s degree from Rutgers University. The source does not establish a degree subject or additional current corporate appointments.

Hakan Baraner leads ZAP Surgical sales across EMEA, Central Asia, Malaysia and Indonesia. His published biography describes more than thirty years in international medical-device and capital-equipment sales. Previous positions include vice president of EMEA sales at ViewRay and commercial responsibilities for Accuray’s CyberKnife and TomoTherapy platforms, as well as ultrasound businesses Aloka and Vingmed Sound. He holds an undergraduate degree from the University of Maryland’s European programme in information-systems management and business studies.

Jinhua Yang has been president of ZAP Surgical China since 2023. The published regional biography describes more than forty years of senior leadership and work on Chinese regulatory and market expansion, including the Beijing office, NMPA processes and local commercial infrastructure. His education includes a bachelor’s degree from Renmin University and a graduate fine-arts degree from UCLA. The regional leadership role is qualified within ZAP’s published group roster and does not establish an additional legal subsidiary or an independent investment vehicle.

Santhosh Krishna Chandrabalan leads strategic growth at ZAP Surgical. The company describes responsibilities spanning growth strategy, new business development, software services and acquisitions. He previously held vice-president and general-manager responsibilities at Cornerstone Building Brands, and senior innovation and venture responsibilities at 3M and GE. His published education includes an MBA from Duke’s Fuqua School and advanced engineering and engineering-management degrees. These outside affiliations are career history, not additional current appointments or personal investment evidence.

Mark Arnold joined ZAP Surgical in 2018 and leads marketing. His biography describes approximately twenty-five years in radiosurgery and radiation-oncology marketing, including serving as Elekta’s global vice president of marketing and holding marketing and product-management responsibilities at Accuray. He earned an MBA from the University of San Diego, with exchange coursework at Oxford’s Magdalen College, and an undergraduate business degree from the University of Nevada, Las Vegas. His published role concerns the medical-device company, not unrelated people with the same surname.

Nikita Kulkarni joined ZAP Surgical as chief financial officer in 2025. Her published biography describes nearly two decades in investment banking, corporate development, investor relations and pharmaceutical research. She previously led corporate development at Halozyme, co-led West Coast healthcare investment banking at Credit Suisse and held corporate-development and investor-relations responsibilities at Varian. Earlier work includes Morgan Stanley, Regeneron and Shire. She holds an MBA from Duke, a biotechnology master’s degree from Northeastern and a pharmacy bachelor’s degree from Mumbai University.

Hemmings Wu, MD, PhD, joined ZAP Surgical as chief medical officer in 2025. His company biography describes a background in neurosurgery, neuroscience and medical technology, including neuromodulation and brain-computer-interface research. He previously worked as a neurosurgeon and research professor at Zhejiang University. He earned his medical degree at Peking University, completed clinical training at Shanghai Jiao Tong University, obtained a doctorate at KU Leuven and undertook postdoctoral research at Stanford. Clinical and device-development objectives remain source-attributed claims.

Derek T. DeScioli joined ZAP Surgical as chief operating officer in 2021. His published biography describes more than twenty years in medical technology and business growth, including leading IntraOp Medical through restructuring and commercial development in radiation oncology. Earlier experience includes 3M, Soliant Energy, Alpha Technologies and Astrodyne TDI. He holds a graduate degree from MIT and an engineering bachelor’s degree from Rutgers. His photograph is an unmodified company-published image naming him at a ZAP-X installation, rather than a generated headshot.

John R. Adler, Jr., MD, founded ZAP Surgical in 2014 and is its chief executive. He invented the CyberKnife radiosurgery system and founded Accuray, and Stanford Medicine lists him as Professor Emeritus of Neurosurgery. His company biography describes Harvard undergraduate and medical training, Harvard neurosurgery training and a Karolinska fellowship with Lars Leksell. He also founded the Cureus medical publishing platform. The listed shareholder filing identifies him as John Rodenbeck Adler Jr.; he is distinct from similarly named politicians and his son Trip Adler. ZAP’s investigational radiomodulation programmes are separate from established device indications.

Product marketing professional featured in Openseed VC’s operator network with a published consumer fintech specialism. Monzo publishes her author page and writing about savings products.

Product management professional featured in Openseed VC’s operator network. Oxford’s 2021 Seed Fund Founders Book names Nick Marcelli among that year’s fund team; this historical affiliation does not establish a current job.

Product marketing professional featured in Openseed VC’s operator network to support early company building. Mercury’s own author biography identifies her former work leading product marketing for new offerings including invoicing and taxes.

Former statutory director of Openseed Ventures Ltd. The company registry records an appointment on July18,2023 and resignation on October4,2023. A venture-investing position or current affiliation with Openseed has not been established.

Founder and general partner of Openseed VC. She previously scaled products and teams at Uber and Branch, led Oxford Seed Fund while studying for an MBA at Oxford, and helped build and co-lead Octopus Ventures’ First Cheque Fund. The registry identifies her as Maria Oluwafunmike Rotilu, an active director of Openseed Ventures Ltd.

Guglielmo Foffani is publicly named by Newronika as Head of Neurophysiology and Neuromodulation - CIEN. The scientific advisory affiliation is separate from the outside academic title listed in the directory.

Aysegul Gunduz is publicly named by Newronika as Prof. Fixed Brain Mapping - University of Florida. The scientific advisory affiliation is separate from the outside academic title listed in the directory.

Sara Marceglia is publicly named by Newronika as Co-Founder, Associate Professor - University of Milan. The scientific advisory affiliation is separate from the outside academic title listed in the directory.

Jens Volkmann is publicly named by Newronika as Neurologist - University of Würzburg. The scientific advisory affiliation is separate from the outside academic title listed in the directory.

Romain Ziouar-Cornec serves as Principal at Omnes Capital. The current directory assigns this position to Portfolio Management. The published career history dates joining the firm or team to April 2023. Earlier professional experience described by the firm includes PwC.

Alexandre Yip serves as Financial Controller at Omnes Capital. The current directory assigns this position to Finance Operations. The published career history dates joining the firm or team to January 2020. Earlier professional experience described by the firm includes Deloitte.

Syed Xeeshan Rizvi serves as Principal at Omnes Capital. The current directory assigns this position to Energy Transition Infrastructure. The published career history dates joining the firm or team to July 2024. Prior utilities work at Vattenfall and Uniper included renewable-energy M&A across wind and solar; he holds a Mannheim MBA.

Martin Thomas serves as Analyst at Omnes Capital. The current directory assigns this position to Portfolio Management. The published career history dates joining the firm or team to October 2025. The biography lists education or professional training at EM Lyon.

Moustapha Singare serves as Manager - Corporate Accounting at Omnes Capital. The current directory assigns this position to Finance Operations. The published career history dates joining the firm or team to November 2021. Earlier corporate-accounting work includes RSM, BNP Cardif, TechnipFMC and Andera Partners.

Antonio Ruscitto serves as Client Servicing Principal - Investor Relations at Omnes Capital. The current directory assigns this position to Investor Relations. The published career history dates joining the firm or team to July 2025. The biography lists education or professional training at HEC. Earlier professional experience described by the firm includes Ardian.

Elena Moro is publicly named by Newronika as Neurologist - University of Grenoble. The scientific advisory affiliation is separate from the outside academic title listed in the directory.

Davide Pra serves as Associate at Omnes Capital. The current directory assigns this position to Energy Transition Infrastructure. The published career history dates joining the firm or team to September 2024. The biography lists education or professional training at Bocconi.

Valérie Petrovic serves as Head of Funds Accounting and Treasury at Omnes Capital. The current directory assigns this position to Finance Operations. The published career history dates joining the firm or team to 2007. Her career includes prior accounting work at Orange and Numéricâble and successive Omnes accounting and treasury promotions.

Alexandre Persyn serves as In-house Counsel at Omnes Capital. The current directory assigns this position to Legal Operations. The published career history dates joining the firm or team to 2008. Earlier professional experience described by the firm includes Crédit Agricole.

Jacky Luu serves as Financial Controller at Omnes Capital. The current directory assigns this position to Finance Operations. The published career history dates joining the firm or team to February 2021. Earlier professional experience described by the firm includes Deloitte.

Wissal Lotfi serves as Risk and Compliance Analyst at Omnes Capital. The current directory assigns this position to Legal Operations. The published career history dates joining the firm or team to December 2023. The biography lists education or professional training at NEOMA.

Chiayen Lin serves as ESG & Sustainability Manager at Omnes Capital. The current directory assigns this position to ESG & Sustainability. The published career history dates joining the firm or team to December 2023. The biography lists education or professional training at KEDGE. Earlier professional experience described by the firm includes Natixis.

Lysia Leclerc serves as Head of the Management Company Accounting at Omnes Capital. The current directory assigns this position to Finance Operations. The published career history dates joining the firm or team to 2005. Previous employment includes Caisse des Dépôts subsidiaries; she holds a management and administration diploma.

Cristina Izquierdo Serrano serves as Associate at Omnes Capital. The current directory assigns this position to Digital Infrastructure. The published career history dates joining the firm or team to February 2024. Earlier professional experience described by the firm includes EY, KPMG.

Anaïs Petitjean serves as Analyst at Omnes Capital. The current directory assigns this position to Portfolio Management. The published career history dates joining the firm or team to March 2025. Earlier professional experience described by the firm includes Rothschild, Natixis.

Aymeric de Susbielle serves as Principal at Omnes Capital. The current directory assigns this position to Energy Transition Infrastructure. The published career history dates joining the firm or team to September 2020. The biography lists education or professional training at ESSEC. Earlier professional experience described by the firm includes PwC.

Quentin Mortreux serves as Analyst at Omnes Capital. The current directory assigns this position to Energy Transition Infrastructure. The published career history dates joining the firm or team to March 2025. Earlier work includes renewable-energy industrial roles in London and Singapore and impact investing in Paris.

Paul Maurens serves as Principal at Omnes Capital. The current directory assigns this position to Venture Capital & Growth. The published career history dates joining the firm or team to September 2022. Earlier professional experience described by the firm includes KPMG.

Arthur Mariaud serves as Principal at Omnes Capital. The current directory assigns this position to Energy Transition Infrastructure. The biography lists education or professional training at Imperial College. Previous energy-investment experience includes PEARL Infrastructure Capital and Aggreko, alongside Imperial College research and teaching.

Marie-Emmanuelle Krantz serves as Paralegal at Omnes Capital. The current directory assigns this position to Legal Operations. The published career history dates joining the firm or team to September 2026. Earlier legal and administrative work includes eight years at Vivien & Associés; she studied languages and British literature.

Marwan Issac serves as Associate at Omnes Capital. The current directory assigns this position to Co-Investment. The published career history dates joining the firm or team to July 2024. The biography lists education or professional training at ESSEC. Earlier professional experience described by the firm includes PwC.

Wael Ilahi serves as IT Manager at Omnes Capital. The current directory assigns this position to Finance Operations. The published career history dates joining the firm or team to January 2025. Earlier professional experience described by the firm includes Crédit Agricole, Société Générale.

Andres Lozano is publicly named by Newronika as Neurosurgeon - University of Toronto. The scientific advisory affiliation is separate from the outside academic title listed in the directory.

Hugo Hubert serves as Principal at Omnes Capital. The current directory assigns this position to Venture Capital & Growth. The published career history dates joining the firm or team to January 2020. His prior training covers data science at Télécom Paris and management and strategy at the London School of Economics.

Clément Henot serves as Analyst at Omnes Capital. The current directory assigns this position to Energy Transition Infrastructure. The published career history dates joining the firm or team to February 2026. His analyst appointment followed an Omnes internship; earlier work includes M&A and investor relations, with emlyon business training.

Stéphanie Fehrenbach serves as Financial Controller at Omnes Capital. The current directory assigns this position to Finance Operations. The published career history dates joining the firm or team to 2015. Earlier fund administration work includes CACEIS and private-equity subsidiaries in the LCL/Crédit Agricole group.

Mathis Fauvarque serves as Analyst - Investor Relations at Omnes Capital. The current directory assigns this position to Investor Relations. The published career history dates joining the firm or team to September 2025. Earlier professional experience described by the firm includes Rothschild.

Imane Essajradi serves as Fund Accounting Associate at Omnes Capital. The current directory assigns this position to Finance Operations. The published career history dates joining the firm or team to February 2026. Earlier RSM private-equity work covered fund accounting and valuation; her graduate education spans ESC Pau and ENCG Agadir.

Karène Dubois serves as HR Officer at Omnes Capital. The current directory assigns this position to Human Resources. The published career history dates joining the firm or team to November 2017.

Soumaya Chouikh serves as Financial Controller at Omnes Capital. The current directory assigns this position to Finance Operations. The published career history dates joining the firm or team to 2023.

Danielle Chucri serves as Executive Assistant to the CEO & Communications Coordinator at Omnes Capital. The current directory assigns this position to Communications, Executive Assistants. The published career history dates joining the firm or team to September 2024.

Léo Chalmel serves as Associate at Omnes Capital. The current directory assigns this position to Energy Transition Infrastructure. The published career history dates joining the firm or team to March 2024. The biography lists education or professional training at EM Lyon. Earlier professional experience described by the firm includes Natixis, Ardian.

Timothée Chailley serves as Analyst at Omnes Capital. The current directory assigns this position to Digital Infrastructure. The biography lists education or professional training at HEC, EDHEC.

Justine Canavy serves as Financial Controller at Omnes Capital. The current directory assigns this position to Finance Operations. The published career history dates joining the firm or team to July 2026. Earlier professional experience described by the firm includes Mazars.

Romain Campi serves as Director at Omnes Capital. The current directory assigns this position to Digital Infrastructure. The published career history dates joining the firm or team to April 2023. The biography lists education or professional training at ESCP. Earlier professional experience described by the firm includes EY.

Cassandra Bouet serves as Head of Compliance and Risk Management at Omnes Capital. The current directory assigns this position to Legal Operations. The published career history dates joining the firm or team to September 2017.

Fabienne Blondeau serves as Financial Controller at Omnes Capital. The current directory assigns this position to Finance Operations. The published career history dates joining the firm or team to February 2022. The biography lists education or professional training at Sorbonne. Earlier professional experience described by the firm includes Crédit Agricole.

David Benayoun is an Accountant in Omnes Capital’s Finance Operations team. He joined the manager in February2020 after accounting work at the Sup de Pub and Sup de créa schools. His published professional education includes a BTS diploma in account management.

Maxence Bédué serves as Associate at Omnes Capital. The current directory assigns this position to Energy Transition Infrastructure. The published career history dates joining the firm or team to September 2024. The biography lists education or professional training at ESSEC. Earlier professional experience described by the firm includes InfraRed Capital Partners, BNP Paribas.

Jayden Aryee serves as Communications Associate at Omnes Capital. The current directory assigns this position to Communications. The published career history dates joining the firm or team to January 2024. Prior internships include LVMH transformation and Hilti recruitment; his BBA is from St.Gallen.

Rihab Aqarrout serves as Analyst at Omnes Capital. The current directory assigns this position to Energy Transition Infrastructure. The published career history dates joining the firm or team to July 2026. Earlier professional experience described by the firm includes Crédit Agricole.

Hassan Al Azadi serves as Principal at Omnes Capital. The current directory assigns this position to Portfolio Management. The published career history dates joining the firm or team to September 2024. Earlier portfolio work includes Tikehau and Access Capital Partners, supported by financial-markets training at Skema.

Thomas Abulius serves as In-house Counsel at Omnes Capital. The current directory assigns this position to Legal Operations. The published career history dates joining the firm or team to February 2024. The biography lists education or professional training at ESCP.

Camille Zimmermann serves as Director at Omnes Capital. The current directory assigns this position to Energy Transition Infrastructure. The published career history dates joining the firm or team to 2023. The biography lists education or professional training at ESCP.

Camille Leonard serves as Director at Omnes Capital. The current directory assigns this position to Energy Transition Infrastructure. The published career history dates joining the firm or team to June 2019. Earlier professional experience described by the firm includes KPMG.

Yasmine Lazrak serves as Director at Omnes Capital. The current directory assigns this position to Co-Investment. The published career history dates joining the firm or team to December 2023. Earlier Bain work in Toronto covered private-equity diligence and performance improvement; she studied commerce at McGill.

Archer Kilpatrick serves as Director at Omnes Capital. The current directory assigns this position to Energy Transition Infrastructure. The published career history dates joining the firm or team to May 2025. Previous renewable-energy work spans project finance, solar development and Actis investments across Africa and Eastern Europe.

Alberto Priori, MD, PhD, is a Newronika co-founder and Chairman of its Scientific Advisory Board. The company identifies him as a University of Milan neurologist; its initial financing release describes his pioneering research on central-nervous-system stimulation as a foundation of Newronika’s technology. He is an author in the company’s current peer-reviewed clinical publication list on adaptive DBS for Parkinson’s disease.

Maia Falkå serves as Director at Omnes Capital. The current directory assigns this position to Venture Capital & Growth. The published career history dates joining the firm or team to October 2022. Earlier roles include LeadX Capital Partners and Simon-Kucher; education spans Exeter and ESB Business School.

Estelle Eonnet serves as Director - Head of Communications at Omnes Capital. The current directory assigns this position to Communications. The published career history dates joining the firm or team to 2023. The biography lists education or professional training at Sciences Po.

Eduardo Bozo serves as Head of Portfolio Management at Omnes Capital. The current directory assigns this position to Portfolio Management. The published career history dates joining the firm or team to January 2024. Earlier Actis experience spans20 years, including Latin America and London and energy/infrastructure chief operating officer responsibilities.

Isaure d’Autichamp serves as Director - Investor Relations at Omnes Capital. The current directory assigns this position to Investor Relations. The published career history dates joining the firm or team to May 2025. The biography lists education or professional training at Dauphine.

Mehdi Abdallah serves as Head of Funds Financial Control at Omnes Capital. The current directory assigns this position to Finance Operations. The published career history dates joining the firm or team to November 2018. The biography lists education or professional training at EM Lyon. Earlier professional experience described by the firm includes Mazars.

Caroline Yametti serves as Partner at Omnes Capital. The current directory assigns this position to Digital Infrastructure. The published career history dates joining the firm or team to 2017. The biography lists education or professional training at HEC. Earlier professional experience described by the firm includes InfraRed Capital Partners, HSBC.

Yannic Trüb serves as Partner at Omnes Capital. The current directory assigns this position to Energy Transition Infrastructure. The published career history dates joining the firm or team to May 2014. The biography lists education or professional training at Sciences Po, University of Zurich.

Benjamin Stremsdoerfer serves as Partner at Omnes Capital. The current directory assigns this position to Energy Transition Infrastructure. The published career history dates joining the firm or team to March 2018. The biography lists education or professional training at Ecole Polytechnique, Imperial College. Earlier professional experience described by the firm includes L.E.K.

Miria Späth-Werder serves as Partner, Head of Sales - Investor Relations at Omnes Capital. The current directory assigns this position to Investor Relations. The published career history dates joining the firm or team to 2016. Earlier professional experience described by the firm includes PwC, Akina.

Grégoire Samain serves as Partner, Head of Project Management and Client Servicing - Investor Relations at Omnes Capital. The current directory assigns this position to Investor Relations. The published career history dates joining the firm or team to 2014. The biography lists education or professional training at Université Paris.

Renaud Poulard serves as Partner at Omnes Capital. The current directory assigns this position to Venture Capital & Growth. The biography lists education or professional training at INSEAD. His earlier Sagem research covered telecoms and defence, followed by venture investing at Seventures; the biography dates his Omnes move to2005.

Morgane Honikman serves as Partner at Omnes Capital. The current directory assigns this position to Digital Infrastructure. The published career history dates joining the firm or team to October 2018. The biography lists education or professional training at ESSEC.

Jean-Baptiste Delattre serves as Partner at Omnes Capital. The current directory assigns this position to Energy Transition Infrastructure. The published career history dates joining the firm or team to January 2018. Earlier ArcelorMittal work included maintenance leadership and responsibility for global energy supplies and strategic energy partnerships.

François-Xavier Dedde serves as Partner at Omnes Capital. The current directory assigns this position to Venture Capital & Growth. The biography lists education or professional training at EM Lyon. Earlier professional experience described by the firm includes Crédit Lyonnais, Crédit Agricole.

Fabien Collangettes serves as Partner at Omnes Capital. The current directory assigns this position to Venture Capital & Growth. The published career history dates joining the firm or team to January 2017. The biography lists education or professional training at Imperial College.

Simon Hardi serves as Partner - Head of Co-Investment at Omnes Capital. The current directory assigns this position to Co-Investment. The published career history dates joining the firm or team to October 2019. Earlier professional experience described by the firm includes L.E.K.

Lina Zovic serves as Partner - CFO at Omnes Capital. The current directory assigns this position to Executive Committee, Finance Operations, ESG & Sustainability. The published career history dates joining the firm or team to September 2024. The biography lists education or professional training at Audencia. Earlier professional experience described by the firm includes KPMG.

Gonzague de Tremiolles serves as Partner - Head of Digital Infrastructure at Omnes Capital. The current directory assigns this position to Digital Infrastructure, Executive Committee. The published career history dates joining the firm or team to 2016. The biography lists education or professional training at Sciences Po, Université Paris, Dauphine.

Philippe Trolez serves as Partner - Corporate Secretary at Omnes Capital. The current directory assigns this position to Executive Committee, Legal Operations. The published career history dates joining the firm or team to 2001. The biography lists education or professional training at HEC.

Serge Rakovitch serves as Partner - COO at Omnes Capital. The current directory assigns this position to Executive Committee, Finance Operations. The published career history dates joining the firm or team to June 2017. The biography lists education or professional training at HEC. Earlier professional experience described by the firm includes Crédit Lyonnais, Deloitte.

Michael Pollan serves as Managing Partner at Omnes Capital. The current directory assigns this position to Energy Transition Infrastructure, Executive Committee, ESG & Sustainability. The published career history dates joining the firm or team to 2013. Earlier professional experience described by the firm includes Natixis.

Michel de Lempdes serves as Managing Partner at Omnes Capital. The current directory assigns this position to Venture Capital & Growth, Executive Committee, Human Resources. The biography lists education or professional training at NEOMA. Earlier professional experience described by the firm includes Crédit Lyonnais, Crédit Agricole.

Marc-Philippe Botte serves as Managing Partner at Omnes Capital. The current directory assigns this position to Energy Transition Infrastructure, Executive Committee, Investor Relations. His earlier career spans teaching at the Free University of Brussels and renewable-energy M&A at Fortis Bank.

Serge Savasta serves as Chief Executive Officer & Chief Investment Officer at Omnes Capital. The current directory assigns this position to Energy Transition Infrastructure, Digital Infrastructure, Co-Investment, Executive Committee. The published career history dates joining the firm or team to 2006. The biography lists education or professional training at HEC. Earlier professional experience described by the firm includes Crédit Lyonnais.

Roshini Jain is publicly named by Newronika as Clinical Strategy. The current affiliation is verified by the company’s own directory as reviewed October8,2026.

Claudia Preziosi is publicly named by Newronika as Business Strategy. The current affiliation is verified by the company’s own directory as reviewed October8,2026.

Blayne Fleck is publicly named by Newronika as Business Strategy. The current affiliation is verified by the company’s own directory as reviewed October8,2026.

Named in Indaco's April2018 launch announcement as one of five key managers who collectively owned51% of the manager. Her disclosed capacity was Investment Director; current affiliation is not established by that historical release.

Giuseppe Galeano is publicly named by Indaco Venture Partners SGR in its governance directory as Statutory Auditor. This is a manager-governance affiliation; additional career history and the term of appointment are not established by this source.

Antonio Mele is publicly named by Indaco Venture Partners SGR in its governance directory as Statutory Auditor. This is a manager-governance affiliation; additional career history and the term of appointment are not established by this source.

Federica Mantini is publicly named by Indaco Venture Partners SGR in its governance directory as Chairman of the Board of Statutory Auditors. This is a manager-governance affiliation; additional career history and the term of appointment are not established by this source.

Marco Seracini is publicly named by Indaco Venture Partners SGR in its governance directory as Board Member. This is a manager-governance affiliation; additional career history and the term of appointment are not established by this source.

Luca Pagetti is publicly named by Indaco Venture Partners SGR in its governance directory as Board Member. This is a manager-governance affiliation; additional career history and the term of appointment are not established by this source.

Alberto Grando is publicly named by Indaco Venture Partners SGR in its governance directory as Board Member. This is a manager-governance affiliation; additional career history and the term of appointment are not established by this source.

Carlo Viola is publicly named by Indaco Venture Partners SGR in its governance directory as Board Member. This is a manager-governance affiliation; additional career history and the term of appointment are not established by this source.

Salvatore Bragantini is publicly named by Indaco Venture Partners SGR in its governance directory as Chairman of the Board. This is a manager-governance affiliation; additional career history and the term of appointment are not established by this source.

Carlo is an Indaco investment manager specialising in healthcare and life sciences. Previously worked atEsaote in diagnostic devices and led technology-transfer projects atIIT RehabTechnologies from2012 to2016. Co-founded Movendo Technology in2017 and served as COO and Product Development Director, including clinical/regulatory development. Holds a Genoa physics degree.

Costanza Conti is publicly named by Newronika as Clinical Affairs Manager. The current affiliation is verified by the company’s own directory as reviewed October8,2026.

Marcello Casali is publicly named by Newronika as Manager - Quality, Regulatory, & Manufacturing. The current affiliation is verified by the company’s own directory as reviewed October8,2026.

engineer and former McKinsey Partner, co-founded Material Economics in2016, acquired by McKinsey in2021. Works closely with companies Navisalma builds.

co-founded Einride in2016 and built its global identity. Current own directory names CEO Navisalma Design; own launch quote identifies Founding Partner.

engineer, founded Einride in2016, now Einride chairman and helps shape companies Navisalma builds.

Mattia Arlotti is publicly named by Newronika as VP - Engineering & New Product Development. The current affiliation is verified by the company’s own directory as reviewed October8,2026.

Ioannis U. Isaias is publicly named by Newronika as Chief Medical Officer. The current affiliation is verified by the company’s own directory as reviewed October8,2026. The visible team card misspells his surname Isais, while the same issuer’s structured Person data and listed peer-reviewed research identify Ioannis U. Isaias/IsaiasIU. The canonical identity follows those corroborating primary records.

Lorenzo Rossi, PhD, is Newronika’s co-founder, Chief Executive Officer and Chief Technology Officer. He is a bioengineer and repeat entrepreneur whose work with Alberto Priori underpins the company’s adaptive deep-brain-stimulation technology. He led the issuer’s 2016 and2019 financing announcements and the September2026 announcement of first ADVENT study implantation. The company’s current directory confirms the combined CEO/CTO role.

Keith Carlton is Newronika’s Executive Chairman, appointed effective immediately on September8,2025. The issuer describes executive leadership experience in medical devices and neuromodulation, including innovation, strategic growth and operational management. Its current directory retains him as Executive Chairman.

Yang Cheng is the member/control person named in iSeed Ventures LLC’s 6 March2026 Form ADV ScheduleA, CRD297342/802-114472. It reports an October2014 appointment and CRD6955614; the exact joining day, operational title and authentic portrait are unpublished in the sources reviewed. The manager’s own LinkedIn page names Bryan Cheng, but a reliable primary alias bridge to this legal name has not been established and no general-partner title is inferred. This scoped legal identity is distinct from the existing Delos Capital associate Yang Cheng; no unrelated academic career or portrait is copied.

Adam How Lin is the managing member and chief compliance officer of iSeed Ventures LLC, confirmed by the adviser’s 6 March2026 Form ADV, CRD297342/802-114472. The filing reports this appointment from October2014 without an exact day. Primary FundIV’s 17 May2024 FormD names Adam Lin as executive officer and managing member of its GP at the same San Francisco office. mySugr’s own 2015 financing release names Adam Lin for iSeed’s early-stage digital-health investment approach and US/China core markets. This investor is distinct from Gunderson Dettmer’s Of Counsel Adam Lin and the Largan executive of that name; no lawyer/industrial executive portrait, degree or biography is borrowed.

Leonie France van Hofwegen is recorded by Companies House as a current designated member of Force Over Mass Capital LLP, appointed February21,2024. This is a statutory LLP capacity, not evidence of an investment-partner or operating job title. The current firm site publishes no individual career biography or caption-bound portrait for her. Her professional history, exact investing responsibilities and any personal investment activity remain unverified.

Abhijit Bhave was identified as Managing Director and CEO of Equirus Wealth in its own October30,2024 Chariots of Fire event announcement. Current tenure is not established by that dated publication; the current directory separately identifies Ankur Punj as Managing Director.

Jinesha Mehta is named as compliance officer in the current issuer disclosure for Equirus InnovateX Fund. The reviewed source does not publish a further biography or appointment date.

Ajit Deshmukh is named in InnovateX’s investment-manager disclosure as a member of its key investment team. Equirus separately describes him as a group Managing Director with investment-banking experience. This establishes the fund-team affiliation without assuming he is Managing Director of the Equirus Wealth legal entity.

Ankur Punj is Managing Director of Equirus Wealth. His career spans banking, wealth management and insurance, including building Equirus’s wealth business and earlier positions with Citibank, Aviva and MetLife.

Ajay Sampath is published as Managing Partner for Equirus Family Office in Equirus Wealth’s own directory. He advises affluent families on wealth preservation, investment growth, asset allocation and intergenerational planning. His previous wealth-management experience includes Standard Chartered, Morgan Stanley and Kotak; the family-office function is distinct from a fund investment role.

Nitesh Arora is published as Managing Partner for Equirus Family Office in Equirus Wealth’s own directory. His career includes wealth-management work at Kotak and Barclays and entrepreneurship. The affiliation is explicitly a family-office function; legal employment by the InnovateX investment manager is not inferred.

Dinesh Nair is published as Director in Equirus Wealth’s wealth-distribution directory. His finance and banking career includes Geojit Private Wealth, Karvy, ICICI Securities, Axis Bank, Kotak and other financial-services firms. He works on business growth, client relationships and wealth distribution.

Krishna Jha is the published fund manager of Equirus InnovateX Fund. He founded mobile-internet company ITFinity, which was acquired by OnMobile, and has been an angel investor since 2011. His work combines entrepreneurship, long-term investing and support for early-stage technology founders.

Sadhika Agarwal is Principal at Equirus InnovateX Fund. She previously founded a consumer brand and worked in investment banking, fundraising and technology-sector mergers and acquisitions. She helps founders with financing, business development and operational execution.

VP Gopan is the issuer’s named InnovateX Venture Partner, also listed as Gopan V P in its legal disclosure. His published biography describes technology-product marketing, strategy and commercial experience at Wipro and Intel across international markets. Initials are preserved; no expanded given name or current outside employment is inferred.

Sunder Nookala is published as an InnovateX adviser in the current issuer directory and as Partner in the February2026 fund-close announcement. A Chartered Accountant and IIM Ahmedabad MBA, he has founded SaaS businesses and supports early-stage startups with mentorship, strategic advice and investment experience. The role-source dates are preserved because the publications use different titles.

Early-stage technology operator and investor with experience in sustainable materials, SaaS growth and data. Co-founded Greewave and has worked on startup equity financing and non-dilutive funding.

Startup ecosystem builder who developed the Sting incubator and initiated Propel Capital and Luminar Ventures. He has supported research-based technology companies across multiple sectors.

Venture investor and corporate partnership builder previously an investment director at Investor Growth Capital and a Combient co-founder. His background includes industrial co-investments and technology company exits.

Venture investor and former deep tech chief executive with previous investment experience at Almi Invest GreenTech and operational experience in B2B technology businesses.